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1. INTRODUCTION 
Propionibacterium freudenreichii is used as a ripening culture in Swiss type cheeses. It 
metabolizes lactate and produces carbon dioxide which results in eye formation in cheese 
body (Thierry et al. 2010). P. freudenreichii also contributes greatly to flavor development 
in cheese (Thierry et al. 2011). Based on long tradition of use, P. freudenreichii has been 
granted both GRAS (generally regarded as safe) and QPS (qualified presumption of safety) 
statuses in the USA and EU, respectively (Mogensen et al. 2002; EFSA 2008). 
Propionic acid bacteria have also emerged as probiotic candidates. They appear to adapt 
well in the gastrointestinal environment. They are known to produce bifidogenic 
compounds and exhibit broad range of other beneficial activities, including antimicrobial 
and antimutagenic properties (Cousin et al. 2011). Propionic acid bacteria are known to 
produce a range of bioactive compounds, including vitamins (cobalamin, folate, riboflavin) 
(Poonam et al. 2012), conjugated linoleic acid (CLA) (Andrade et al. 2012) and short chain 
fatty acids (Jan et al. 2002).  
P. freudenreichii is also used in industrial production of vitamin B12 (cobalamin) (Martens 
et al. 2002). It utilizes anaerobic B12 biosynthetic pathway which includes about 30 
enzyme-driven reactions (Raux et al. 2000). The pathway has been elucidated fully except 
for biosynthesis of cobalamin lower ligand – 5,6-dimethylbenzimidazole (DMBI). DMBI 
as a lower ligand is highly important for cobalamin biological activity. In humans, only 
two enzymes are cobalamin dependent: methionine synthase and methylmalonyl-CoA 
transferase (Martens et al. 2002). If DMBI is replaced with other bases, B12-like 
compound becomes inactive for humans, e.g. pseudocobalamin containing adenine in the 
lower ligand position (Vorobjeva 1999; Hazra et al. 2013). 
In industrial process of vitamin B12 production which is conducted anaerobically, DMBI 
is added to the growth medium which allows achieving high levels of cobalamin 
production (Wang et al. 2012). Alternatively, the process is conducted in two steps 
including anaerobic incubation for a few days followed by switch to aeration mode. With 
oxygen supply provided, the biosynthesis of own bacterial DMBI is stimulated (Martens et 
al. 2002). 
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P. freudenreichii produces DMBI in oxygen dependent pathway from riboflavin (Renz and 
Weyhenmeyer 1972) . This pathway is not well understood yet. It is known to be catalyzed 
by BluB enzyme which belongs to ‘flavin destructase’ family (Taga et al. 2007). The 
enzyme was found in both in anaerobic (Bacillus megaterium) (Gray and Escalante-
Semerena 2007) and aerobic (Sinorhizobium meliloti) (Campbell et al. 2006) producers of 
vitamin B12.  
In this work a proteomic approach was used to explore the effect of DMBI on global 
protein production by type strain of P. freudenreichii. Proteomics is a common tool for 
investigation of physiological responses to different stimuli in bacterial cells (Han et al. 
2011). Gel-based proteomic technique was previously applied in P. freudenreichii to study 
the mechanisms of bile (Leverrier et al. 2003), heat (Anastasiou et al. 2006) and acid 
adaptation (Jan et al. 2001).  
The aim of this thesis was to study the effect of exogenous DMBI in growth medium on 
vitamin B12 synthesis in type strain of P. freudenreichii ssp. freudenreichii. Vitamin B12 
production was evaluated in two types of processes (fully anaerobic and two step system). 
The second constituent of the study was the investigation of protein production in P. 
freudenreichii. Proteome maps were obtained at the mid-logarithmic growth stage for the 
cultures grown in presence and absence of DMBI. They were used to detect and identify 
proteins expressed differentially between two conditions.  
The literature review introduces general features of P. freudenreichii species and its 
metabolism. The role of propionic acid bacteria in cheese is discussed as well as the 
potential to be used in other fermented products. Different aspects of probiotic potential of 
propionic acid bacteria are introduced including data from in vitro and in vivo studies. 
Vitamin B12 biosynthesis is outlined with special place dedicated to lower ligand 
structure. Biosynthesis of DMBI from riboflavin via aerobic pathway is described in 
details. The strategies of enhancing cobalamin productivity in industrial applications are 
discussed. Finally, proteomics as a tool to study bacterial cell metabolism is introduced 
including the overview of strengths and disadvantages. An insight into proteomic data 
available for P. freudenreichii is made.  
11 
 
 
2. LITERATURE REVIEW 
2.1 Overview of P. freudenreichii 
2.1.1 General characteristics of P. freudenreichii species 
Genus Propionibacterium belongs to Actinobacteria class, family Propionic acid 
bacteriaceae. They are Gram-positive, rod shaped, non-motile, non-sporeforming, 
generally catalase positive bacteria characterized by high G+C content (64-67 mol%). 
Phylogenetic distinction between species is based on 16S rRNA gene sequence. Propionic 
acid bacteria are mainly anaerobic to aerotolerant and may be microaerophilic (Whitman et 
al. 2012).  
The genus Propionibacterium includes 12 species divided into two groups based on their 
habitat (Cousin et al. 2011): 
1) Dairy propionic acid bacteria: P. acidipropionici, P. cyclohexanicum, P. 
freudenreichii, P. jensenii, P. microaerophilum, P. thoenii 
2) Cutaneous propionic acid bacteria: P. acidifaciens, P. acnes, P. australiense, P. 
avidum, P. granulosum, P. propionicum. 
Dairy (or classic) propionic acid bacteria can be found in other than  milk-derived foods 
including fruits and vegetables (Mantere-Alhonen 1995; Vorobjeva et al. 2008). In 
addition, they are also found in soil and silage (Whitman et al. 2012). 
P. freudenreichii is a type species of the genus. It was named after Swiss bacteriologist 
Eduoard von Freudenreich who first isolated and described the species. In 1906 in co-
authorship with Orla-Jensen he showed relation of eyes formation in cheese with propionic 
acid producing bacteria. The first genome of P.freudenreichii strain CIRM-BIA1
T
 
(CIP103027) was sequenced a few years ago by Falentin et al. (2010). 
P. freudenreichii species includes nowadays two subspecies: freudenreichii and shermanii. 
They are traditionally distinguished by two features: nitrate reduction and lactose 
fermentation. P. freudenreichii ssp. freudenreichii is able to reduce nitrate and lacks the 
ability to ferment lactose. By contrast, P. freudenreichii ssp. shermanii metabolizes lactose 
but lacks nitrate reduction (Whitman et al. 2012).  
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2.1.2 Metabolism of P. freudenreichii 
Propionic acid bacteria have low nutritional requirements and are able to survive in very 
unfavourable conditions. They may grow without the addition of amino acids (Whitman et 
al. 2012). The genome sequence defined for P. freudenreichii strain CIRM-BIA1
T
 was 
found to encode pathways for synthesis of all vitamins excluding those for pantothenate 
and biotin (Falentin et al. 2010). Accordingly, all strains examined to date require only 
pantothenate and biotin for growth (Whitman et al. 2012). Propionic acid bacteria can 
catabolize a variety of carbon sources, including sugars (D-glucose, D-mannose, rhamnose, 
galactose, lactose, sucrose, trehalose), lactate and alcohols (glycerol, mannitol, adonitol, 
erythriol) (Whitman et al. 2012).  
The genus Propionibacterium is generally characterized by high production of propionic 
acid. Propionate is produced by a pathway named Wood-Werkman or transcarboxylase 
cycle (Fig. 1). The pathway is characterized by high ATP yield. In propionic acid bacteria 
it is the main way of energy generation (Vorobjeva 1999).  
 
Figure 1. Wood-Werkman cycle in P. freudenreichii (adapted from Thierry et al. 2011) 
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The essence of Wood-Werkman cycle is the reduction of pyruvate to propionate. One of 
the key reactions is transcarboxylation between methylmalonyl-CoA and pyruvate yielding 
oxaloacetate and propionyl-CoA. This reaction is catabolized by biotin-dependent 
methylmalonyl-CoA carboxytransferase without energy consumption. Oxaloacetate then 
enters tricarboxylic acid cycle (TCA cycle) where it is converted to succinate. As a result 
of reduction of fumarate to succinate ATP is generated. Propionyl-CoA exchanges 
coenzyme A group with succinate yielding propionate which is mediated by CoA 
transferase. Finally, methylmalonyl-CoA mutase converts succinyl-CoA to 
methylmalonyl-CoA. The enzyme uses adenosylcobalamin (vitamin B12) as a cofactor. 
(Thierry et al. 2011). 
In order to maintain redox potential, part of pyruvate is oxidized to acetate and carbon 
dioxide (Thierry et al. 2011). The ratio propionic:acetic acid is typically 2:1, but may reach 
5:1 or higher (Dworkin et al. 2006). Genome sequencing by Falentin et al. (2010) 
reconstituted both Wood-Werkman pathway and oxidative decarboxylation pathways.  
Although P. freudenreichii are predominantly anaerobic, they possess necessary genes for 
respiration in aerobic condition such as NADH dehydrogenase, succinate dehydrogenase, 
cytochrome bd complex, ATPase and the complete pathway for heme synthesis (Falentin 
et al. 2010). The response to oxygen is known to be strain-dependent (Vorobjeva 1999).  
Some strains of P. freudenreichii possess aspartase activity. Aspartate is metabolized to 
succinate (via fumarate) and ammonia. This affects lactate fermentation by re-directing to 
CO2 and acetate formation (Crow 1986). Excessive aspartase activity in strains used in 
cheese-making causes the risk of late fermentation which may lead to split defects. 
Aspartase activity is therefore considered when selecting strains for cheese-making (Blasco 
et al. 2011). 
2.1.3 Role or propionic acid bacteria in cheese ripening 
The primary use of propionic acid bacteria in food fermentations is ripening cultures for 
Swiss-type cheeses (Thierry et al. 2010). This is partly due to its comparatively high 
thermotolerance, enabling this starter culture to reach levels as high as 10
9
 CFU/g (Thierry 
et al. 2011). The most well-known variety of Swiss type cheeses is Emmental. The 
characteristic step in technology of Emmental includes the step of cooking at 50-60
oС for 
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about 30 min which constitutes stress for cheese microflora. The ripening is accomplished 
at warm temperature 18-24
o
C for at least 4-6 weeks (Thierry et al. 2010). 
During ripening in Swiss type chees propionic acid bacteria anaerobically utilize lactate 
derived from lactose fermentation performed by lactic acid bacteria, yielding propionate, 
acetate and carbon dioxide. Accumulation of carbon dioxide results in formation openings 
(eyes) in cheese body.  
Propionic acid bacteria contribute greatly also to cheese flavor formation during ripening. 
They produce a wide range of non-volatile and volatile compounds (Thierry et al. 2010). 
Volatile compounds result from the catabolism of branched-chain, aromatic, and sulfur-
containing amino acids. Propionic acid bacteria were shown to significantly influence the 
amount of 57 out of the 69 volatiles in cheese juice (Thierry et al. 2004). In small scale 
Swiss cheeses production propionic acid bacteria increased levels of all carboxylic acids 
and 14 out of 58 neutral flavor compounds as compared to cheese ripened without them 
(Thierry et al. 2005). Being added as adjunct culture to traditional Raclette cheese it 
significantly affected the level of 16 volatile compounds and increased the level of free 
fatty acids two- to five-fold. Cheese then received higher scores for odor and flavor 
intensity in sensory evaluation (Thierry et al. 2005). 
One of the most important branched-chain flavor compounds produced by propionic acid 
bacteria in cheese are 3-methylbutyric acid and 2-methylbutyric acid. The former is 
referred to as isovaleric acid. These acids are derived from leucine and isoleucine 
catabolism, respectively (Thierry et al. 2004). Isoleucine was found to be converted more 
efficiently than leucine resulting in prevalence of 2-methylbutyric acid over 3-
methylbutyric acid (approximately 80:20) (Thierry et al. 2011). As it was reviewed by 
Thierry et al. (2002), these acids along with isobutyric and isocaproic acids render the 
cheese sweaty, fruity, sweet, cheesy and fatty acid-like flavor (Thierry and Maillard 2002). 
The levels of methylbutyric acids were 3 to 10 times higher (depending on strain) in 
presence of propionic acid bacteria in the starter culture although they do not appear to be 
the only producers (Thierry et al. 2004). Leucine and isoleucine catabolism starts with 
transamination yielding in α-ketoacid followed by its decarboxylation and oxidation in one 
or several steps to form final volatile acid (Thierry et al. 2004; Thierry et al. 2011). 
Propionic acid bacteria also significantly affect lipolysis of milk fat and free fatty acids 
(FFA) release although this activity is strain specific. FFAs impart cheese pungent, rancid, 
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cheesy and fruity notes (Collins et al. 2003). In presence of propionic acid bacteria FFA 
levels were two to eight times higher than in their absence. In recent work, it was shown 
that the secreted esterase encoded by the P. freudenreichii CIRM-BIA1
T
 gene pf279 is the 
main lipolytic enzyme involved in Swiss cheese ripening process. Inactivation of the pf279 
gene reduced the lipolytic activity by 75% compared to that of the wild-type strain 
(Abeijon Mukdsi et al. 2014). 
Formation of esters in cheese is also significantly affected by propionic acid bacteria. Both 
the variety of esters and their level are improved. Some esters can be found only at 
presence of propionic acid bacteria, mainly those composed of propionate and acetate that 
are supplied from lactate fermentation. Propionic acid bacteria are likely to contribute also 
to ester synthesis (Thierry et al. 2004). 
Flavor in cheese is known to develop during ripening at warm temperature and continue 
during cold storage. This is to high extent due to the activity of propionic acid bacteria 
maintained at cold temperatures. It was shown that 20% of propionate and acetate, ~25% 
of short chain FFA, ~41% of long-chain FFA, ~60% of branched-chain acids from 
isoleucine and leucine catabolism, and ~80% of esters are formed during cold storage of 
cheese (Thierry et al. 2005). 
2.1.4 Propionic acid bacteria as probiotics 
2.1.4.1 Safety and adaptation in GIT 
Probiotic is defined as “a live microorganism which, when administered in adequate 
amounts, confers a health benefit on the host” (FAO 2006). Dairy propionic acid bacteria 
emerged as probiotic candidates and that has been shown in numerous studies in vitro, ex 
vivo, in vivo in animal models and humans (Cousin et al. 2011). The first evidence of 
propionic acid bacteria as monoculture delivering health benefits were shown in animal 
study involving piglets. The administration of P.freudenreichii with fodder resulted in 
better weight gain, lowered feed demand and less diarrhea in piglets (Mantere-Alhonen 
1995). 
Dairy propionic acid bacteria are recognized to be safe for humans. For instance, in a study 
with P. freudenreichii ssp. shermanii that was given in a mixture with other three 
probiotics to infants for six months, no risks for health were registered (Kukkonen et al. 
2008). Based on the long term application in cheese making they acquired both ‘Generally 
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recognized as safe’ (GRAS) from American Food and Drug Administration (FDA) 
(Mogensen et al. 2002) and ‘Qualified presumption of safety’ (QPS) status from the 
European food safety authority (EFSA) (EFSA 2008).  
Propionic acid bacteria express tolerance to digestive tract environment including acidity 
and bile salts. Bile salts are animal detergents that are highly toxic for microorganisms 
(Leverrier et al. 2003). Acid and bile tolerance appear to be a strain dependent feature. 
Many strains can survive pH values as low as 4.0 (Yuksekdag et al. 2014). And there are 
strains with excellent survival rate at pH 3.0 (Suomalainen et al. 2008) It is noteworthy that 
probiotics delivered with certain vectors like fermented foods express higher tolerance to 
digestive stress than pure cultures (Cousin et al. 2011). This was shown, for instance, 
during in vitro studies with fermented milk (Leverrier et al. 2005). Detection of viable cells 
after passage through GIT was reported in a few in vivo studies; high numbers of P. 
freudenreichii could be found in feces of human microbiota-associated rats (Lan et al. 
2007). Viable cells of P. freudenreichii ssp. shermanii JS strain have also been detected in 
feces of adult volunteers (Suomalainen et al. 2008). 
The number of dairy propionic acid bacteria in human gut is low but their colonization 
levels can be increased through oral administration (Vorobjeva et al. 2008). Propionic acid 
bacteria are able to adhere to the intestinal cells, which was shown both in vitro and in 
animal model (Cousin et al. 2011). The studies involving human intestinal mucosa 
indicated that propionic acid bacteria  displayed comparatively low adhesion efficacy 
(Thiel et al. 2004). P. freudenreichii ssp. shermanii strain was shown to be able to adhere 
both to human and mice intestinal epithelial cells, and porcine mucus (Zárate et al. 2002; 
Yeruva et al. 2011). In a recent study involving piglets, P. freudenreichii strain 
demonstrated adaptability and physiological activity in the colon environment (Saraoui et 
al. 2013). 
2.1.4.2 Bifidogenic properties 
Propionic acid bacteria can promote growth of well-established probiotic microorganisms 
such as Bifidobacterium. They are known to produce two bifidogenic growth stimulators 
(BGS): 1,4-dihydroxy-2-naphthoic acid (DHNA) and 2-amino-3-carboxy-1,4-
naphthoquinone (ACNQ) (Cousin et al. 2011). DHNA is a precursor of vitamin K 
(menaquinone), it also stimulates intestinal bifidobacteria and ACQN may be derived from 
DHNA (Isawa et al. 2002, Cousin et al. 2011). ACQN as a growth stimulator of 
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Bifidobacterium was discovered in cell-free extract of P. freudenreichii (Yamazaki et al. 
1999). Thus, it enhances the activity of NADH oxidase and NADH peroxidase. 
Administration of P. freudenreichii culture resulted in significantly increased percentage of 
bifidobacteria in fecal flora of humans as well as stool frequency (Kaneko 1999).   
Propionic acid bacteria intake results in a significant increase in bifidobacteria counts and 
general improvement of intestinal microbiota (Hojo et al. 2002). There is evidence on 
synergistic effect of propionic acid bacteria species in co-cultures with other probiotics. In 
a study on human intestinal cell culture P. jensenii 702 was shown to promote adherence of 
bifidobacteria (Moussavi and Adams 2010).  
2.1.4.3 Antimicrobial activity 
Propionibacterium spp. strains express antimicrobial activity mainly against Gram-
negative spp. (Yuksekdag et al. 2014), as well as antifungal activity (Ho et al. 2009). P. 
freudenreichii ssp. shermanii JS was shown to aggregate with pathogenic cells, preventing 
their colonization and infection of GIT (Collado et al. 2008).  
Dairy propionic acid bacteria were found to inhibit Helicobacter pylori. H. pylori is a 
pathogen that causes chronic gastritis and is a risk factor for gastric cancer. Eradication 
therapy by combination of antibiotics brings about detrimental alterations in gut 
microbiota. However, it is possible to counteract these effects through probiotic treatment. 
P.freudenreichii ssp. shermanii JS was used in with other probiotics for patients 
undergoing H. pylori eradication therapy. Administration of probiotics improved tolerance 
to eradication treatment as compared to placebo group and increased recovery of probiotic 
bacteria in feces was achieved (Myllyluoma et al. 2005). This strain inhibited adhesion of 
H. pylori to epithelial cells and hindered H. pylori-induced release of interleukin 8 in vitro, 
which constituted anti-inflammatory effect. (Myllyluoma et al. 2008). 
2.1.4.4. Immunomodulation, anticancerogenic and antimutagenic activities 
Immunomodulatory activity of P.freudenreichii ssp. shermanii JS was demonstrated also 
in adults. In healthy adults receiving probiotic-containing drink for three weeks, serum 
level of C-reactive protein (a sensitive marker of inflammation) was decreased (Kekkonen 
et al. 2008). 
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Propionic acid bacteria were shown in vitro to reduce effects of a number of cancer risk 
factors including mycotoxins, cyanotoxins, plant lectins, some heavy metals such as 
cadmium and lead. Since they are able to reduce gut absorption of these compounds in 
vivo, the risk of colorectal cancer may be lowered (Cousin et al. 2011). 
Conjugated linoleic acid (CLA), an isomer of linoleic acid with conjugated double bond, 
which possesses biological activity, is mainly derived from dairy products (Bhattacharya et 
al. 2006). In numerous in vitro and animal models CLA have been shown to have several 
health benefits: anticarcinogenic, antiatherogenic, antiadipogenic, antidiabetogenic and 
anti-inflammatory properties. Thus, CLA-enriched products are of high interest 
(Bhattacharya et al. 2006). CLA production by microorganisms is strain dependent and 
many strains of propionic acid bacteria are CLA positive, including strains of both P. 
freudenreichii ssp. shermanii and freudenreichii (Andrade et al. 2012). 
Short-chain fatty acids (SCFA) produced by propionic acid bacteria (namely propionate 
and acetate) were shown to induce apoptosis of colorectal carcinoma cells. In vitro studies 
showed that acetate and propionate are directly affect mitochondria resulting in loss of 
transmembrane potential, mitochondrial swelling and generation of reactive oxygen 
species (Jan et al. 2002).   
Dairy propionic acid bacteria also demonstrated antimutagenic activity, i.e. reduced levels 
of spontaneous and induced mutations (Vorobjeva and Abilev 2002). Vorobjeva et al. 
demonstrated that propionic acid bacteria suppress mutations caused by 4-nitro-quinoline 
and N-nitro-N-nitrosoguanidine as well as 9-aminoacridine and 2-nitrofluorene (Vorobjeva 
et al. 2008). The mechanisms involve protein factor but are not fully elucidated yet 
(Vorobjeva and Abilev 2002). 
2.1.4.5 Propionic acid bacteria as probiotics in fermented foods 
In the light of probiotic potential propionic acid bacteria species were employed for food 
fermentations other than cheese. Propionic acid bacteria were proposed as delivery vectors 
facilitating adaptation of propionic acid bacteria to digestive stresses and enhancing the 
efficacy of action (Cousin et al. 2012). 
An early work by LeBlanc et al. (2006) used P. freudenreichii NIZO B2336, a spontaneous 
roseoflavin-resistant mutant derived from P. freudenreichii B374, in combination with 
commercial starter culture to produce yogurt. The mutant strain is characterized by high 
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riboflavin (vitamin B2) production. Propionic acid bacteria counts in yogurt were as high 
as 5×10
8
 cfu/g. The product fed to rats resulted in improved riboflavin status of previously 
depleted animals (LeBlanc et al. 2006).  
In recent work Farhadi et al (2013) inoculated milk with adjunct starter cultures with P. 
freudenreichii ssp. shermanii and L. acidophilus. The study was focused on production of 
propionic acid which can be used as natural food preservative. P. freudenreichii 
maintained count of 9×10
6
 cfu/ml which proved fermented milk environment to be good 
environment for bacteria. Fermentation temperature 30
o
C and inoculation ratio 1:4 of L. 
acidophilus to P. freudenreichii ensured maximal count of the latter as well as highest 
level of propionic acid (Farhadi et al. 2013). 
The first dairy product (fermented milk) exclusively fermented by P. freudenreichii was 
proposed by Cousin et al (2012). Since propionic acid bacteria grow poorly in milk, the 
milk needs to be supplemented with lactate and casein hydrolysate. The P. freudenreichii 
strain was cultured in the modified milk medium and the fermentation was performed for 
three days at 30
o
C. This resulted in population levels of 10
9
 cfu/g, which is equal to counts 
reported for cheeses (Thierry et al. 2011). Propionic acid bacteria showed good tolerance 
to in vitro and in vivo stresses; the bacteria remained viable during cold storage at 4
o
C for 
at least 15 days, which is important for microorganism to be considered as probiotic. The 
effect of fermented milk in vivo was evaluated on piglets, demonstrating high survival rate 
of the tested P. freudentreichii strain in the gut evidenced by the presence of propionate 
and acetate formed by this strains (Cousin et al. 2012).  
2.2 Vitamin B12: structure, biosynthesis and role 
2.2.1 Vitamin B12 structure 
Vitamin B12 was first found to be a curing factor for pernicious anemia in 1926. It was 
isolated and crystallized in 1948. And its structure was deeply characterized by Dorothy 
Hodgkin in 1956 (Raux et al. 2000, Warren et al. 2002). Vitamin B12 (cobalamin) belongs 
to the group of compounds called corrinoids.  Corrinoid molecule consists of two basic 
parts: planar corrin ring in the center and nucleotide at a right angle to it (Fig. 2). Corrin 
ring is comprised of four pyrroles. Two of them (rings A and D) are linked directly to each 
other which is a unique feature of corrinoids that distinguishes them from porphyrins, e.g. 
heme. Corrin ring is coordinated around cobalt atom via bonds between pyrrol nitrogens 
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and metal. Nucleotide is a lower axial ligand of cobalt. Cobalamin is the form of corrinoids 
in which nucleotide is represented by 5,6-dimethylbenzimidazole (DMBI). DMBI is 
covalently attached to cobalt via one of its nitrogens. The second nitrogen is linked to 
ribose phosphate. The latter is, in its turn, is attached to D-pyrrole ring through 
aminopropyl residue. Thus, a so-called nucleotide loop is formed (Warren 2006; Miller and 
Green 2007). 
 
Figure 2. Cobalamin structure (Warren 2006; Miller and Green 2007) 
 
Cobalamins as a group of compounds are distinguished by the identity of the upper ligand, 
the third part of the molecule. In coenzyme forms the upper ligand is mainly represented 
by   -deoxyadenosyl or methyl in adenosylcobalamin and methylcobalamin, respectively. 
Hydroxycobalamin, more rarely, but still can be a coenzyme form. Strictly speaking, the 
term vitamin B12 is restricted to cyanocobalamin which has CN group as an upper ligand. 
It is the most stable pharmacological form of the vitamin. All other forms are converted to 
cyanocobalamin in the presence of light and cyanide ions (Miller and Green 2007). In 
various Bacteria and Archaea several other forms of cobalamin are found, e.g. 
glutathionylcobalamin, sulfitocobalamin, and nitritocobalamin, but their functions are not 
yet well understood (Miller and Green 2007). 
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Apart from cobalamin, bacteria can produce a variety of cobamides with different lower 
ligands, including different benzimidazoles, purines and phenolic compounds (Fig. 3) 
(Hazra et al. 2013). The forms lacking nucleotide moiety at all are called cobinamides, e.g. 
cobinamide phosphate, guanosine diphosphate-cobinamide (GDP-cobinamide), which are 
formed under conditions unfavorable for benzimidazole synthesis. The form in which 
benzimidazole is replaced by adenine is called pseudo-B12. P. freudenreichii synthesizes 
incomplete forms as well as pseudo-B12 in small amounts (Vorobjeva 1999). 
 
Figure 3.  Lower ligands structures  
The identity of lower base ligand affects binding catalytic ability of cobamide coenzyme 
forms (Hazra et al. 2013). Binding of cobamides occurs in two forms. In base-off form 
lower ligand is not coordinated to cobalt. Such cobalamin-dependent enzymes as 
methionine synthase, methyl-malonyl-CoA mutase bind coenzyme in this mode. Having no 
bond with cobalt, DMBI is replaced by histidine residue of apoenzyme (Ludwig and 
Matthews 1997). In base-on mode DMBI remains coordinated to cobalt. In this form 
cobalamin is bound to such enzymes as ribolucleotide reductase, diol dehydratase, etc. 
(Hazra et al. 2013).   
2.2.2 Vitamin B12 biosynthesis 
In nature, cobalamin synthesis is restricted to certain microorganisms only. A few genera 
are known to be B12 producers: Aerobacter, Agrobacterium, Alcaligenes, Azotobacter, 
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Bacillus, Clostridium, Corynebacterium, Flavobacterium, Micromonospora, 
Mycobacterium, Norcardia, Propionibacterium, Protaminobacter, Proteus, Pseudomonas, 
Rhizobium, Salmonella, Serratia, Streptomyces, Streptococcus and Xanthomonas. 
However, mainly Pseudomonas denitrificans and Propionibacterium freudenreichii are of 
industrial importance. The advantage of P. freudenreichii is the fact that it has GRAS 
status, therefore cobalamin from them is food grade (Martens et al. 2002). 
The components of complex B12 molecule (corrin ring, upper ligand and nucleotide) are 
synthesized separately followed by assembly. Biosynthetic pathway of cobalamin at early 
steps is common to other tetrapyrrols which have corrin ring in the structure, including 
haem, chlorophyll, sirohaem and coenzyme F430. The common precursor of the core 
structure is 5-aminolaevulinic acid (ALA) (Fig. 4). It is converted to uroporphyrinogen III 
(UroIII) and at this stage B12 synthesis follows pathway which is separate from haem and 
chlorophyll (Roth et al. 1996; Raux et al. 2000).  
 
 
Figure 4. Cobalamin biosynthesis overview (Raux et al. 2000; Warren et al. 2002) 
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B12 biosynthesis pathway can be divided into three steps: synthesis of corrin ring, 
synthesis of nucleotide, assembly of the components (Raux et al. 2000). The whole 
synthesis includes around 30 enzyme-catalyzed steps (Vorobjeva 1999; Raux et al. 2000). 
Corrin ring is formed resulting from transformation of uroporphyrogen III. This 
transformation includes peripheral methylations and ring contraction, which results in 
direct linking of pyrolles A and D (Raux et al. 2000; Warren 2006).  
The stage of corrin ring formation can be accomplished by one of the two distinct 
pathways by bacteria: anaerobic and aerobic (Fig. 5) (Raux et al. 2000; Warren et al. 
2002). This separates bacteria into two types. P. freudenreichii as well as Salmonella 
typhimurium and Bacillus megaterium synthesize B12 using anaerobic pathway. 
Pseudomonas denitrificans is a well-studied aerobic B12-producer (Martens et al. 2002). 
The difference between these pathways is in the timing of cobalt insertion and the 
mechanism of ring contraction (Warren et al. 2002). Accordingly, the pathways contain 
specific enzymes (Rodionov et al. 2003). 
In anaerobic pathway used by P. freudenreichii cobalt insertion occurs at an early stage 
when the ion is inserted to the intermediate called precorrin-2 (Fig. 5). Cobalt is thought to 
mediate catalysis of subsequent ring contraction. By contrast, in aerobic pathway cobalt 
insertion takes place at the late stage after all major transformations in precorrin ring are 
completed (Raux et al. 2000; Warren et al. 2002).  
Anaerobic and aerobic pathways proceed the same way from the step of adenosyl-cobyric 
acid (in case of adenosylcobalamin formation). It is converted to cobinamide by 
attachment of aminopropanol moiety. Then, cobinamide is activated via phosphorylation 
and formation of GDP-cobinamide. The last step of coenzyme formation is the attachment 
of the lower ligand base (DMBI). Before that, DMBI is activated by the attachment of 
phosphoribosyl moiety. The resulting compound is joined to GDP-cobinamide forming the 
nucleotide loop and releasing GMP (Warren et al. 2002; Martens et al. 2002). 
The activation of DMBI base is regulated by cobT gene encoding nicotinate 
mononucleotide (NaMN):base phosphoribosyltransferase. It catalyzes formation of alpha-
ribazole-5'-phosphate from nicotinate mononucleotide and DMBI. In P. freudenreichii 
CIRM-BIA1
T
 genome cobT is fused with bluB gene which encodes nitroreductase 
(Falentin et al. 2010). Database search in UniProtKB showed that this fusion gene 
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BluB/CobT has been reported only in P. freudenreichii CIRM-BIA1
T
 and Kitasatospora 
setae so far. 
 
Figure 5. Aerobic and anaerobic cobalamin biosynthetic pathways (adapted from Warren et al. 2002) 
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BluB gene product emerged as a DMBI synthesizing enzyme. However, the mechanism of 
the synthesis has not been elucidated yet (Taga et al. 2007).  Recent studies showed that 
CobT enzyme might be responsible for structural diversity of cobamides. The enzyme was 
shown to phosphoribosylate benzimidazole, purine and phenolic bases (Cheong et al. 2001; 
Hazra et al. 2013). CobT gene product appears to lack substrate specificity which results in 
the diversity of cobamides that can be synthesized by one species (Chan et al. 2014). 
However, in a recent study seven CobT homologues were tested with a variety of bases 
and six of them exhibited preference for DMBI if it was present in the environment (Hazra 
et al. 2013; Crofts et al. 2013).  
2.2.3 DMBI biosynthesis: anaerobic and aerobic pathways 
DMBI is an important component in the industrial production of cobalamin as it promotes 
formation of vitamin B12. It is used to for supplementation of medium and can be added at 
different stages of fermentation. Bacteria utilize exogenous DMBI complete cobalamin 
biosynthesis by attaching it to cobinamide (Wang et al. 2012). Biosynthesis of DMBI by 
bacteria themselves remains elusive although some recent findings enable better 
understanding.  
Two biosynthetic pathways of DMBI are known: anaerobic and aerobic. Bacteria utilizing 
anaerobic pathway use glycine, glutamine, formate, erythrose-4-phosphate, and methionine 
for DMBI synthesis. This pathway was studied in strict anaerobe Eubacterium limosum. 
Glycine, formate and erythrose-4-phosphate donate carbons, whereas nitrogen is derived 
from glutamine (Renz 1998). 
In species synthesizing DMBI only aerobically it is produced via enzyme-catalyzed 
pathway from riboflavin. It was first suggested that DMBI is derived from riboflavin as 
they have common structure. Radiolabelling studies showed that radioactivity from 
riboflavin was incorporated into vitamin B12 and, more specifically, to DMBI moiety 
(Renz 1970)   ater it was specified that it is   -14C in riboflavin molecule that is transferred 
to C-2 position of DMBI as it was shown in P. freundenreichii (Renz and Weyhenmeyer 
1972). This conversion was thought to be catalyzed by a constitutive enzyme system 
although no enzyme involved was recognized (Renz 1998). Hörig and Renz showed that 
flavin mononucleotide (FMN) is an immediate substrate for DMBI formation (Horig and 
Renz 1980). 
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2.2.4 BluB – DMBI-synthesizing enzyme  
The enzyme for oxygen-dependent conversion of riboflavin to DMBI through FMN was 
unknown until 2006, when Campbell et al. suggested that BluB enzyme catalyzes this 
reaction. BluB was first proposed to be involved in the conversion of cobinamide to 
cobalamin in Rhodobacter capsulatus (Pollich and Klug 1995). The enzyme acquired its 
name as blu genes play role in ‘blushing’ of R. capsulatus after reduction of partial O2 
pressure (Warren 2006).  The bluB gene was previously suggested to encode a candidate 
cobalt reductase and was identified in various cobalamin-producing species (Rodionov et 
al. 2003). 
In the research by Campbell et al. the production of acidic polysaccharide succinoglucan 
by nitrogen-fixing bacterium Sinorhizobium meliloti was investigated. It was found that the 
mutants exhibiting unusually bright fluorescence on calcofluor-containing medium had an 
inactivated gene that showed 36% homology to bluB gene of R. capsulatus. The mutants 
appeared to be unable to grow either in the absence of DMBI or only in presence of 
cobinamide. They were found to synthesize an intermediate (GDP-cobinamide) unless 
DMBI was provided. BluB mutants of S. meliloti were the first DMBI auxotrophs reported. 
Thus, it was concluded that BluB is required for the aerobic synthesis of DMBI (Taga et al. 
2007).  
BluB is an enzyme which belongs to NADH/FMN-dependent nitroreductase family 
(Campbell et al. 2006). The enzyme was crystalized and structure investigated by the same 
research group. It exhibited structural similarity to flavin oxidoreductase and functional 
relatedness to mono-oxidases (Taga et al. 2007). 
Taga et al. also reported that it was a reduced form of FMN (FMNH2) that was consumed 
by BluB, although a separate enzyme is responsible for the NAD(P)H-dependent reduction 
of FMN. BluB itself was found to cleave ribityl tail of FMN yielding D-erythrose 4-
phosphate (Fig. 6). The activity of BluB includes breakage of three bonds and formation of 
one as well as contraction of six-membered ring of FMNH2 yielding a five-membered ring 
of DMBI. For this oxygen-dependent reaction no NAD(P)H appeared to be required. 
Furthermore, the enzyme was assigned to a new family of ‘flavin destructases’ (Taga et al  
2007). 
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BluB protein was soon also identified in Rhodospirillum rubrum. BluB mutants of this 
bacterium appeared to be deficient in the reaction of bacteriochlorophyll biosynthesis 
catalyzed by B12-dependent enzyme. The activity was restored by addition of DMBI, 
cobalamin or introduction of plasmid encoding the wild type allele of bluB. Thus, BluB 
was established to be necessary and sufficient for oxygen-dependent conversion of FMNH2 
to DMB. No metals or organic factors were required. In contrast to S. meliloti, R. rubrum 
due to lack of BluB function accumulated cobyric acid, an intermediate of de novo corrin 
biosynthetic branch of the pathway (Gray and Escalante-Semerena 2007). 
In the research by Wang and Quan (2011) the identification of BluB-catalyzed reaction 
mechanism was explored by hybrid density functional method. The analysis allowed 
distinction of two separate stages of the reaction and divide it into at least 14 steps. The 
first stage is thought to involve incorporation of oxygen followed by fragmentation of 
alloxazine ring of FMNH2 yielding alloxane and ribityl dimethylphenylenediimine (Fig. 6). 
The second stage can include at least ten steps which leads in the formation of DMBI and 
release of D-erythrose 4-phosphate. Thus, relatively simple structure of BluB enzyme 
appears to contradict the complexity of the described multifunctional catalysis (Wang and 
Quan 2011).  
Yu et al. investigated the diversity of S. meliloti mutants which had point mutations located 
in conserved residues in the active site of BluB  The domain has a unique structure of ‘lid’ 
that is thought to shield the active site from solvent. Some mutants demonstrated weakened 
binding affinity to both FMN and FMNH2. The mutants also had severely reduced DMBI 
synthesis, thus, exhibiting loss of BluB catalytic function. This showed the importance of 
active site residues for DMBI biosynthesis (Yu et al. 2012). 
In recent work Collins et al. first demonstrated bluB expression in species utilizing 
anaerobic pathway of B12 biosynthesis, namely Bacillus megaterium. Species discussed 
before (S. meliloti, R. rubrum) synthesize B12 under aerobic conditions. This work also 
first experimentally demonstrated an intermediate of FMN destruction, 4a-peroxyflavin. 
However, it was only found in reaction by R. capsulatus (Collins et al. 2013). 
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Figure 6. BluB-catalyzed oxygen-dependent DMBI synthesis 
 
Experiments by Maggio-Hall et al. (2003) presented facile non-enzymatic conversion of 
riboflavin to DMBI in a cascade of oxidative reactions. This phenomenon was thought to 
be responsible for low DMBI levels found in S. meliloti bluB mutant strains (Yu et al. 
2012). 
2.2.5 Improvement of vitamin B12 production by P. freudenreichii 
Cobalamin productivity is strain-dependent. Thirty seven strains of P.freudenreichii were 
screened for B12 production by Hugenschmidt et al. (2010). Cobalamin levels were in the 
range 0-2.5 µg/ml (Hugenschmidt et al. 2010). Berry and Bullerman (1966) reported the 
level as high as 15 µg/ml in a two-step process (Berry and Bullerman 1966). 
The improvement of B12 production by P. freudenreichii can be achieved by three ways: 
1) Two-step production with aeration provided at the late stage of incubation 
2) Addition of DMBI 
3) Genetic manipulation 
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Industrial cobalamin production using P.freudenreichii is conducted in a two-step process. 
First, in anaerobic stage, cobinamide formation takes place.  Then, the culture is 
transferred to aerobic condition when DMBI moiety is synthesized and attached to 
cobinamide yielding coenzyme form (Speedie and Hull 1960; Martens et al. 2002).  This 
switch is also governed by growth regulation needs. Oxygen is known to be an essential 
factor in growth of B12-producing strains of P. freudenreichii. Large amounts of 
propionate accumulated under anaerobic condition naturally inhibit the bacteria. When 
aerated, propionate in the media decomposes eliminating inhibition factor. Higher cell 
density is achieved and volumetric vitamin productivity increases (Ye et al. 1996). 
Aeration appears to have a positive effect on its own and the level of air supply was not 
found to have effect on B12 productivity (Berry and Bullerman 1966). 
In order to promote cobalamin synthesis in industrial fermentation, exogenous DMBI is 
introduced (Wang et al. 2012). Its optimal level was established to be 15 ppm. (Marwaha et 
al. 1983) although in some research the level as high as 10 ppm (Berry and Bullerman 
1966) and 20 ppm (Yongsmith et al. 1982) were reported as ensuring highest B12 yields. 
DMBI was recommended to be added to culture medium at the late stage of growth.  
Marwaha et al. reported that optimal infusion time of sterile DMBI is 24 h before the end 
of fermentation (with 168h as a total duration of the process). Earlier introduction of the 
precursor was found to suppress the growth of P. shermanii culture and higher levels of 
B12 could be achieved when DMBI infusion was delayed (Marwaha et al. 1983). 
However, the study by Wang et al. (2012) did not show inhibition of growth although it 
confirmed the importance of DMBI infusion timing for coenzyme B12 biosynthesis. The 
highest productivity was observed when DMBI was introduced to P. freudenreichii culture 
at 84 h of incubation. At this point the highest level of cobinamide was observed (Wang et 
al. 2012). 
Manipulation of genes involved in cobalamin biosynthesis is another way of increasing 
vitamin production. Modified strains are able to produce levels as high as 300 mg/l. B12 
productivity is commonly improved by random mutagenesis (Martens et al. 2002). 
Recombinant strains of P. freudenreichii expressing genes as hemA (encoding ALA-
synthesizing enzyme), cobA (encoding uroporphyrinogen III methyltransfrerase), cbiL and 
cbiF (encoding precorrin-5 synthase and precorrin-8 synthase, respectively) were shown to 
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produce 1,5-2,2 fold higher levels of B12 depending on gene compared to non-
recombinant one (Piao et al. 2004).  
2.2.6 Vitamin B12 dependent enzymes 
Cobalamin is known to be a cofactor for three types of enzymes: isomerases, 
methyltransfereases and dehalogenases (Banerjee and Ragsdale 2003). In bacteria and 
archaea a number of important reactions are catalyzed by vitamin B12 dependent enzymes: 
acetogenesis, methanogenesis, ribonucleotide reduction, fermentation and dehalogenation 
(Banerjee and Ragsdale 2003).  
In propionic acid bacteria, methylmalonyl-CoA mutase is of particular importance for 
Wood-Werkman cycle. The enzyme converts succinyl-CoA to methylmalonyl-CoA 
(Thierry et al. 2011). Besides propionic acid fermentation, in P. freudenreichii vitamin B12 
is known to be involved in DNA synthesis, ribonucleotide reductase and glutamate mutase 
activity, stabilization of thiol groups in enzymes, methylation of cytosine residues in DNA, 
etc. (Vorobjeva 1999). 
In mammals, including humans, B12 is a cofactor of only two enzymes: methylmalonyl-
CoA mutase and methionine synthase (Martens et al. 2002). Methylmalonyl-CoA mutase 
is an adenosylcobalamin dependent enzyme and participates in propionyl-CoA metabolism 
(Fig. 1). Propionyl-CoA is first carboxylated to form methylmalonyl-CoA. Then, the 
enzyme catalyzes conversion to succinyl-CoA which is then involved in tricarboxylic acid 
cycle (Fig. 7). Propionyl-CoA accumulation results from degradation of valine, thymine, 
methionine and odd chain fatty acids, etc. B12 deficiency brings about acidosis due to 
accumulation of methylmalonic acid (Martens et al. 2002).  
 
Figure 7. Methylmalonyl-CoA catalyzed reaction 
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Figure 8. Methionine synthase catalyzed reaction 
 
Methionine synthase is methylcobalamin dependent enzyme. It catalyzed transfer of 
methyl group from 5-methyltetrahydrofolate to homocysteine to form methionine (Fig. 8) 
(Ludwig and Matthews 1997). Vitamin B12 deficiency results in accumulation of 
homocysteine (Martens et al. 2002). 
2.2.7 Vitamin B12 deficiency in humans 
Cobalamin is essential for animals including humans. Due to inability to synthesize B12 
we derive it from food sources. Plants and fungi are not known to use B12 in their 
metabolism or to produce it (Roth et al. 1996).  Recommended intake for adults is 2.4 
µg/day (FAO (WHO) 2002). Humans derive B12 mainly from food of animal origin: meat, 
milk, eggs, fish, and shellfish. Besides, some plant sources and mushrooms can contain 
substantial levels of B12 (Watanabe et al. 2013).  
B12 deficiency is prevalent among elderly people. Besides, vegetarians, especially strict 
ones (vegans) are affected due to limitation or absence of animal derived foods in their 
diet. The problem also takes place in developing countries with high levels of poverty 
which does not allow consuming enough sources of vitamin B12 (Watanabe et al. 2013).  
Indicators of B12 deficiency are decreased serum level of cobalamin as well as increased 
blood levels of methylmalonic acid due to impaired methylmalonyl-CoA mutase activity 
and homocysteine (also in urine) due to inactivation of methioinine synthase (Miller and 
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Green 2007). Cobalamin deficiency mainly affects blood (results in anemia) and nervous 
system (causing neuronal demyelination) (Miller and Green 2007). 
Deficiency in elderly people is often connected with malnutrition, malabsorption due to 
gastric and intestinal causes. Chronic gastritis, gastric atrophy and other problems cause 
impaired B12 absorption. All the disorders associated with intestine, especially terminal 
ileum (site for physiological absorption of cobalamin), also cause B12 deficiency (Miller 
and Green 2007).  
Prevention of deficiency in vegetarians and elderly can be achieved through diet. 
Vegetarians can include plant-derived food enriched with B12: soyabean-fermented foods, 
edible algae (laver), various edible mushrooms (black trumpet and golden chantarelle), 
some vegetables (broccoli, asparagus, Japanese butterbur, mung bean sprouts, tossa jute, 
and water shield). For elderly people with B12 malabsorption it is recommended to 
consume B12-fortified products, e.g. cereals and milk (Watanabe et al. 2013). 
2.3 2D electrophoresis as a tool for investigation of bacterial proteome 
2.3.1 Principle of 2D electrophoresis 
The term ‘proteomics’ was introduced in  996 and refers to the study of overall protein 
pool produced in a cell, tissue or an organism (Rogowska-Wrzesinska et al. 2013). There 
are two main approaches on bacterial proteome investigation: two-dimensional gel 
electrophoresis (2D GE) and gel-free shotgun proteomics (Chao and Hansmeier 2012).  
2D GE involves separation of proteins in two stages. First dimension is separation of 
proteins according to their net charge, or isoelectric point, in the process named isoelectric 
focusing (IEF). The second stage is sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), which is separation according to molecular weight (Mw) 
(Chao and Hansmeier 2012). The workflow of proteome investigation using 2D-GE is as 
follows (Rabilloud and Lelong 2011): 
1) Sample preparation 
2) IEF 
3) SDS-PAGE 
4) Visualization  
5) Image analysis, detection of spots with differential abundance 
6) Proteins identification 
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Sample preparation is a crucial step in gel-based protein separation which involves 
solubilization and purification of proteins. This is achieved by using a combination of 
chaotropic compounds and neutral detergents. Since proteins charge must not be changed 
uncharged chaotropes such as urea coupled with thiourea are used. Combination of urea 
and thiourea disrupts hydrogen bonds resulting in protein unfolding and prevention of 
interactions between molecules (Lopez 2007). To improve dissolving of cellular lipids and 
maintaining proteins soluble during IEF, electrically neutral detergent 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) is added. CHAPS is a 
surfactant that prevents protein molecules from hydrophobic interactions, aggregation and 
precipitation (Posch 2008; Rabilloud and Lelong 2011). Hydrophobic proteins, such as 
membrane-associated ones, are the hardest to solubilize. Hence, they can be excluded from 
the analysis. The use of SDS, which is an excellent solubilizing agent, would assist in 
dissolving membrane-associated proteins. However, SDS is incompatible with IEF (Lopez 
2007). 
At present, IEF is conducted using immobilized pH gradient strips (IPG) which improves 
reproducibility. There are several pH ranges available commercially from very narrow (pH 
4-5) to very broad (3-10) (Lopez 2007). Prior to transfer to SDS-PAGE, IEF gels are 
equilibrated in SDS-containing buffer. SDS binds to the protein molecules and renders 
them the same net charge density. Proteins become mobile in polyacrylamide gel in the 
second dimension. Equilibration buffer contains dithiothreitol (DDT) which reduces 
disulfide bridges, thus unfolding tertiary structure. It is also necessary to protect sulfhydryl 
groups from oxidation. For this, iodacetamide is added to equilibration buffer (Drabik et al. 
2013).  
Visualization of separated proteins in the gels can be achieved by using various staining 
techniques. The most applied are Coomassie Brilliant Blue, silver and fluorescent dyes 
(Lopez 2007). Silver staining is very sensitive with the detection limit as low as 0.1 ng 
protein. However, it has narrow dynamic range and it is the least reproducible of all stains 
(Drabik et al. 2013). Nevertheless, silver staining is useful for qualitative determination of 
spots (presence/absence) (Lopez 2007). Coomassie Brilliant Blue is an organic dye which 
shows  moderate sensitivity (8-10 ng) (Drabik et al. 2013) as well as good linearity and 
excellent compatibility with mass spectrometry(Rabilloud and Lelong 2011) which is now 
widely used for proteins identification. Fluorescent dyes, e.g. Sypro Orange used in this 
work, appear to be a compromise variant of the first two. Its sensitivity is as low as 1 ng 
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(Drabik et al. 2013). And it shows excellent linearity and is compatible with mass 
spectroscopy (Rabilloud and Lelong 2011). 
2.3.2 Capacities and limitations of 2D GE 
Proteomics nowadays is an indispensable method for large-scale analysis of physiology 
and metabolism in microorganisms. It enables understanding of physiological responses to 
a variety of stimuli. Proteomic approach was applied to study the mechanisms of 
physiological response to high and low temperatures, acid stress, organic solvents, 
oxidation, etc. (Han et al. 2011). 
2D GE method allows to visualize up to a few thousands protein spots simultaneously 
(Drabik et al. 2013). 2D GE proteomics enables analysis of post-translational 
modifications: phosphorylation, glycolization as well as modification by oxidative stress 
(Sa-Correia and Teixeira 2010; Chao and Hansmeier 2012). Modifications, such as 
phosphorylation, glycolization, acetylation and deamidation, induce shift in pH value of 
proteins. This results in dislocation of spot on the proteome map (Rabilloud and Lelong 
2011). 
2D GE also enables quantitative analysis. It can be achieved via labelling as well as label 
free methods. Labelling methods include stable isotopes, isobaric mass tagging, chemical 
labelling (Han et al. 2010). The most common technique now is application of isotope-
coded affinity tagging reagents (ICAT). Proteins are labelled with heavy and light ICAT 
reagents. After trypsin digestion quantification is accomplished based on relative signal 
intensities of identical peptides (Phillips and Bogyo 2005).  
2D GE is a powerful tool for investigation of bacterial proteomes which are comparatively 
simple. However, the proteins that 2D-GE is able to resolve are those that are highly 
abundant and soluble. They perform limited number of basic functions, i.e. central 
metabolism, protein synthesis, degradation, stress response (Rabilloud and Lelong 2011).  
One of the important shortcomings is low ability to resolve hydrophobic proteins, 
especially membrane-associated ones (Rabilloud and Lelong 2011). These proteins are 
involved in some important functions, such as adhesion, signal transduction, ion transport. 
Hydrophobic proteins are estimated to account for about 30% of cell proteome (Drabik et 
al. 2013). Gel visualization techniques limit the ability to detect low abundance proteins 
that may be present in a few copies per cell. Basic proteins are often missed out in 2D gels. 
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However, they may constitute a significant part of bacterial proteome (Lopez 2007). 
Commercially available IPG strips for basic pH range are known to have lower resolution 
compared to acidic strips (Drabik et al. 2013). 
2.3.3 Proteomic studies on P. freudenreichii 
The published proteomic studies on P. freudenreichii were mainly focused on its 
adaptability to abiotic and biotic stresses. This is due to probiotic potential of the species. 
Probiotics intended for use in food should tolerate technological stress (temperature, 
osmotic stress, acidity) and then they should tolerate conditions of gastrointestinal tract 
(gastric acid and bile salts) (Gagnaire et al. 2009).  
An early study by Jan et al. (2001) was focused on acid stress adaptation by P. 
freudenreichii ssp. shermanii SI41. The study demonstrated the ability to develop acid 
tolerance response (ATR) by the cultures exposed to sublethal pH of 5.0 for 60 min. The 
procedure induced ATR development by bacterial cells. This resulted in maintenance of 
viability and high survival rates during challenge at lethal pH 2.0 as opposed to non-
adapted cells. During adaptation treatment the total of 433 proteins separated by 2D GE 
were found to be synthesized. The synthesis had a time-dependent pattern. Proteins could 
be divided into those induced at early or late growth stage, as well as transiently or 
permanently. The protein pool induced by acid stress included general stress response 
proteins GroEL, GroES, which were synthesized at the late stage of adaptation. Another 
group of proteins relating to early response included enzymes involved in DNA synthesis 
and repair (RecR and RepB) and biotin carboxyl carrier protein (BCCP). BCCP is involved 
in decarboxylation of methylmalonyl-coenzyme A and carboxylation of pyruvate, the key 
reactions of Wood-Werkman cycle (Jan et al. 2001). 
Leverrier et al. (2003) investigated bile salt stress on the same strain of P. freudenreichii. 
Adaptation strategy was also applied when cells were exposed to solution containing 0.2 g 
bile salts/l. This enabled to achieve high survival rate at lethal concentration of bile (1.0 g 
bile salts/l), the level exceeding that in a healthy human gut. Protein production was 
investigated after adaptation. Pre-treatment was found to induce 24 proteins of which five 
were synthesized de novo. Bile stress induced proteins included general stress response 
proteins such as DnaK, Hsp20, ClpB as well as BCCP and RecR, previously associated 
with acid stress. There were also proteins assigned to oxidative stress adaptation: 
superoxide dismutase SodA and cysteine synthase CysK. Another group of proteins was 
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proposed to be responsible for signal sensing and gene expression regulation: histidine 
kinase, alternative sigma factor AlgU and RpoE (Leverrier et al. 2003). 
Follow-up study by Leverrier et al. (2004) covered three types of stresses: acid, bile salts 
and heat and common pathways of stress response were found for them. Six proteins were 
found to be induced commonly by different stresses, including aforementioned conserved 
heat shock proteins DnaK, ClpB, SodA and BCCP. Acid stress was specifically found to 
trigger the overproduction of enolase, malate dehydrogenase, GroEL, pyruvate flavodoxin-
ferredoxin oxidoreductase and elongation factor EF-Tu involved in polypeptide 
metabolism. The following proteins were specifically induced by bile stress: as previously, 
superoxide dismutase and cysteine synthase, and ABC transporter OppD. Heat stress did 
not induce many specific proteins. Only a single-strand binding protein was found to be 
overproduced specifically in this case and its role is to respond to DNA-damaging agents 
(Leverrier et al. 2004). 
 Anastasiou et al. (2006) demonstrated by transcriptome-level analyses the thermotolerance 
in P. freudenreichii is strain-dependent feature. Proteomic study was conducted on several 
native strains isolated from traditional Graviera Kritis, a Gruyere-type cheese. The 
manufacture includes heat treatment at 52-53
o
C, which requires microflora to be 
thermotolerant. In accordance with heat stress response, all the strains were categorized 
into heat tolerant and heat sensitive groups. The two groups had distinct but overlapping 
heat stress response patterns. Tolerant strains were found to activate molecular chaperones, 
antioxidant protection and stringent response mechanisms. Overproduction of the 
following proteins was detected: chaperonin Cpn60, ClpB homologue, pyruvate-
flavodoxin reductase, S-adenosylmethionine synthase (MetK), pyridine nucleotide–
disulphide oxidoreductases, polyribonucleotide: ortho-phosphate nucleotidyltransferase. 
By contrast, sensitive strains tended to adapt through activation of signal translation, 
biosynthetic pathways, and cell wall maintenance and protein turnover. Heat stress induced 
overproduction of the following proteins: GroEL, DnaK, elongation factor EF-Tu GTP 
binding domain, enzymes synthesizing pyrimidine, thiamine, histidine, cysteine synthase, 
D-alanine-D-alanine ligase, H31 response regulator (Anastasiou et al. 2006).  
A recent study of Dalmasso et al. (2012) addressed metabolism of P.freudenreichii in 
ripened cheese during cold storage at around 4
o
C, since it is known to remain active in this 
condition and continue to utilize nutrients and produce flavor compounds (Thierry et al. 
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2011). Responses at transcriptome-levels as well as at protein production levels during 
cold storage were studied. The investigation was conducted not in cheese but in a system 
mimicking ripening cheese, with lactate as the only carbon source and rich in soluble 
nitrogen. Accordingly, energy metabolism, amino acids and protein synthesis genes were 
down-regulated and cold stress markers were overexpressed. Among them stress response 
transcriptional protein PspC, CspA and CspB were found. Heat shock proteins were down-
regulated: GroSL, DnaKJ, Hspp20, ElpB, GrpB. Volume of some proteins was found to be 
decreased: DnaK2, GroS1, ClpB2, Hsp20. Being affected by cold stress, metabolism was 
redirected towards glycogen synthesis through gluconeogenesis. Lactate dehydrogenase 
was maintained and pyruvate phosphate dikinase as well as glycogen synthesis enzymes 
were up-regulated. In addition, the maintenance of Wood-Werkman cycle, fat hydrolysis 
and ester synthesis were evidence of cells activity (Dalmasso et al. 2012). 
Thus, proteomic studies on dairy propionic acid bacteria are in infancy with limited 
number of conditions investigated. Due to probiotic potential and various health benefits 
that these bacteria demonstrate, more investigation is required towards their physiological 
activities. 
3. EXPERIMENTAL RESEARCH 
3.1 AIM OF RESEARCH 
The aim of this work was to investigate the effect of DMBI on vitamin B12 synthesis and 
protein production in P. freudenreichii spp. freudenreichii DSM 20271. For this the 
following objectives were achieved: 
1) Vitamin B12 production was determined in the presence and absence of DMBI 
in growth medium at mid-logarithmic growth stage, and overall vitamin B12 
productivity was evaluated after 168 h incubation. The effect of two-step 
process on final cobalamin level was evaluated in comparison to fully anaerobic 
process. 
2) Proteome maps of P. freudenreichii ssp. freudenreichii cultures grown in the 
presence and absence of DMBI were obtained at mid-logarithmic growth stage.  
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3.2 MATERIALS AND METHODS 
3.2.1 Bacteria and culture conditions 
P. freudenreichii ssp. freudenreichii strain DSM 20271 obtained from the German 
Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany) was 
investigated. This is a type strain of P. freudenreichii ssp. freudenreichii that is unable to 
metabolize lactose. 
The strain was cultured on propionic acid (PPA) agar with lactate as a carbon source. The 
composition of PPA was as follows: 5.0 g tryptone (Sigma-Aldrich, Co, USA),  10.0 g 
Bacto™ yeast extract (Becton, Dickinson and Co, France),  15.0 g Bacto™ agar (Becton, 
Dickinson and Co, France) and 0.84% (w/v) sodium DL-lactate added in the form of 60% 
(w/w) syrup (Sigma-Aldrich, Co, USA) in 1 l MiliQ water. pH was adjusted to 7.3 by the 
addition of 2M NaOH (Mallinckrodt Baker B.V., Holland) in solid medium. The media 
were autoclaved at 121
o
C for 15 min. 
Liquid PPA media was prepared analogously, but without the addition of agar. Liquid PPA 
with increased level of carbohydrate source contained 3% (w/v) sodium DL-lactate. The 
value of pH in this medium is usually adjusted to 6.7 prior autoclaving. However, since 
lactate decreases pH of the medium after autoclaving, the required pH was achieved by 
over-adjusting pH up to 7.4 prior to autoclaving. In PPA with standard level of lactate, pH 
was adjusted to 6.7. After autoclaving at 121
o
C for 15 min the resulting pH values in PPA 
with 0.84 and 3% lactate were 6.61 and 6.59, respectively. 
Liquid PPA was supplemented with cobalt chloride (Sigma-Aldrich, Germany) at a level 
of 5 ppm (Berry and Bullerman 1966). The samples to be containing 5,6-
dimethylbenzimidazole (Merck, Germany) as a precursor (samples DMBI+) were 
supplemented with DMBI at a level of 15 ppm (Marwaha et al. 1983) at incubation time 0. 
The required amounts of cobalt chloride and DMBI solutions were filtered using 0.2 μm 
Whatman® Nylon filter media (Schleicher&Schnell, USA) and added directly to sterile 
media before inoculation. For each condition (DMBI+ and DMBI-) six replicate cultures 
were prepared.  
The cultures were grown anaerobically at 30
o
C. Three out of six cultures for each 
condition were grown for 168 h fully anaerobically. The other three were grown in a two-
step fermentation process, including 72 h anaerobic incubation followed by transfer to 
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aerobic condition where the cultures were incubated for the rest 96 h. Anaerobic conditions 
were obtained by culturing the strains in anaerobic jars with Aerocult®A reagent (Merck 
KGaA, Germany). Aerobic condition was provided by leaving tube caps slightly loose. 
3.2.2 Growth kinetics 
The growth in liquid PPA was monitored by measuring optical density (OD) at 600 nm 
(OD600) using spectrophotometer (Novaspec® II, Amersham Pharmacia Biotech, Sweden) 
and 1.5 ml cuvettes (Brand GMBH, Germany). The pH of the culture samples and media 
was measured with 744 pH meter (Metrohm Ltd, Switzerland).  
For inoculation of liquid cultures, bacteria were first cultivated on PPA agar at 30
o
C for 3 
days. Cells were harvested and re-suspended in 1 ml PPA to obtain OD600 of  0.01, which 
was used to inoculate the culture media (45 mL). 
Three conditions were investigated: bacterial cells cultured in PPA, PPA supplemented 
with 3% lactate and 5 ppm cobalt chloride, PPA supplemented with 3% lactate, 5 ppm 
cobalt chloride and 15 ppm DMBI. For each sample 45 ml of media in 50 ml Cellstar® 
tubes (Greiner Bio-One GmbH, Germany) were inoculated and for or each condition, two 
biological replicates were analyzed. The optical density was determined every 4 hours until 
the growth stopped, i.e. no obvious increase in cell densities was observed. In addition, pH 
was measured in each sample at every 24 hours starting from inoculation point. 
3.2.3 Culturing for B12 analysis 
For B12 analysis, bacterial cells were harvested at two time points of growth: first, at the 
same time as for 2D GE analysis at the mid-logarithmic stage and, second time, after 168 
h. For the first harvest, bacteria were cultivated in 250 ml glass bottles using 230 ml of 
liquid PPA medium. For both DMBI(+) and DMBI(-) conditions, three biological 
replicates were used. At the time of 168 h harvesting (OD600 4.1-4.9), each cultures were 
divided into  five 50 ml Cellstar® tubes (Greiner Bio-One GmbH, Germany). These 
samples (50 mL) were centrifuged for 10 min at 3220 × g in the centrifuge 5810 R 
(Eppendorf, Germany) at 4°C and the cells were re-suspended in 5 ml of ice cold PBS 
buffer. Cell pellets of the same sample were combined in one tube and the cells harvested 
by centrifugation  for 10 min, 18514 × g at 4°C. The samples were stored at -20
o
C before 
analysis. 
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The procedure of harvesting at 168 h was analogous to 24 h harvest. However, due to the 
fact that the late stationary cultures appeared to give very soft pellets after second 
centrifuging pellets were transferred to 1,5 ml Eppendorf tubes and centrifuged at 21500 × 
g for 10 min in the centrifuge Himac CT 15RE (Hitachi Koki Co., Ltd, Japan). This 
allowed more complete separation of supernatant, although the pellets were still softer 
compared to the ones obtained after 24 h incubation. The samples were stored at -20
o
C 
before analysis. 
3.2.4 UHPLC quantification of vitamin B12 level 
Extraction and UHPLC analysis were conducted according to Chamlagain et al. 
Intracellular total cobalamins were extracted from the cells as cyanocobalamin 
(Chamlagain et al. 2015). 
Frozen cell pellets were thawed at room temperature. Approximately 0.1 g of cells was 
weighed in plastic thermoduric tube. 10 ml of extraction buffer (pH 4.5) composed of 8,3 
mmol/l sodium hydroxide (Merck, Germany) and 20.7 mmol/l acetic acid (Merck, 
Germany) was added to the samples followed by pipetting 100 μl of 1% sodium cyanide 
solution (Sigma-Aldrich, Germany) to each sample. After vortexting the samples were 
incubated for 30 min in a boiling water bath and cooled on ice. Next, the samples were 
centrifuged using Hermle Z323 (HERMLE Labortechnik GmbH, Germany) at 8000 rpm 
for 10 min and supernatants were collected in clean plastic tubes. Pellets were re-
suspended in 5 ml extraction buffer (pH 6.2), centrifuged again and supernatants were 
collected. pH of the combined supernatants was adjusted to 6.2, which was followed by 
filtering through a qualitative filter paper (Ø 90 mm, VWR, France) to 25 ml volumetric 
flasks. The flasks were filled up with extraction buffer (pH 6.2). Before UHPLC analysis 
samples were filtered through 0.2 μm Acrodisk® filters (Pall Corporation, USA) into 12 × 
32 vials (Waters, USA). The rest of the samples were transferred to plastic bottles and 
stored at -20
o
C. 
The UHPLC system consisted of Acquity UPLC® HSS T3 column (1.8 μm, 2.1 × 100 
mm) and a guard column, Waters Acquity™ Ultra Performance LC, photodiode array 
detector, sample manager and binary solvent manager (Waters, USA). Chromatographic 
data was acquired using Empower 2 software. The analysis was performed at column 
temperature of 30
o
C. Mobile phase was composed of 0.025% trifluoroacetic acid (TFA) 
(Sigma-Aldrich, Germany) in MilliQ water (solvent A) and 0.025% TFA in acetonitrile 
41 
 
 
(Sigma-Aldrich, Germany) (solvent B). The flow rate was set at 0.32 ml/min.  Injection 
volume was  0 μl  The mobile phase was a series of gradient steps including the following 
proportions of solvent A:solvent B : range 0-0.50 min 95:5; range 0.50-5.00 min linear 
gradient of solvent B from 5 to 40%; range 5.00-6.00 min 60:40; range 6.00-7.00 min 
linear gradient of solvent A from 60 to 95%; range 7.00-10.00 min 95:5. Each sample was 
injected twice. Cyanocobalamin in effluent was detected at 361 nm. 
The standard curve was prepared with cyanocobalamin solutions. Stock solution with the 
concentration of 0.2 mg/ml was made by diluting cyanocobalamin (Supelco; Bellefonte, 
USA) in 25% aqueous ethanol solution. The stock solution was stored in the dark at 4
o
C. 
The actual concentration was measured right before UHPLC analysis by a 
spectrophotometer. For spectrophotometric determination stock solution was 10-fold 
diluted with 25% aqueous ethanol solution. The absorbance was measured at 361 nm in 
duplicate with 25% aqueous ethanol solution as a blank. Cyanocobalamin level was 
calculated using the equation: 
           
               
    
, 
where A361 – absorbance of cyanocobalamin stock solution at 361 nm; MWCN-Clb – 
cyanocobalamin molecular weight (1355.4 g/mol). 
3.2.5 Culturing and harvesting for 2DE analysis 
The bacteria were cultured in 50 ml Cellstar® tubes (Greiner Bio-One GmbH, Germany) 
using 45 ml of PPA medium inoculated. Harvesting cell samples was conducted at the 
mid-logarithmic stage of growth (24 h post inoculation) with cultures having OD600 of 0.56 
- 0.91. From each tube two aliquots of 10 ml were transferred to 15 ml tubes (Greiner Bio-
One GmbH, Germany). The rest of the culture was left for the second B12 analysis (see 
below). Logarithmic cultures were centrifuged (10 min, 3220 × g, 4°C) using the 
centrifuge 5810 R (Eppendorf, Germany), and the pelleted cells were washed using  10 ml 
of 50mM ice cold Tris-HCl (pH 8.0) (PlusOne, GE Healthcare, Sweden) and centrifuged 
again as described above. For more complete removal of supernatant pellets were 
transferred to 1.5 ml Eppendorf tubes and centrifuged at 21500 × g and 4
o
C for 10 min. 
Samples were stored at -20
o
C before analysis. 
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3.2.6 Protein extraction, solubilization, purification and quantification 
During extraction, solubilization and purification, unless stated differently, cell pellets 
were kept on ice in order to avoid degradation of the proteins. Before extraction 50 μl of 
0.2 M Tris (PlusOne, GE Healthcare, Sweden) was added to cell pellets. After this the cell 
samples were transferred to 1.5 ml microcentrifuge tubes with skirt (Greiner Bio-One 
GmbH, Germany) and cells were broken using Fast Prep-24 (M.P. Biomedicals, USA) in 
presence of sterile glass beads Ø = 0.1 mm (Sigma-Aldrich). The lysis included 3 × 30 s 
cycles at the speed of 6.5 m/s. The pellets were held on ice in between the cycles for 1 min.  
Proteins released after lysis were dissolved in 300 μl UTC-T buffer composed of 7 M urea 
(GE Healthcare), 2 M thiourea (Merck KGaA), 4% 3-[(3-cholamidopropyl)-
dimethylammonio]-1-propanesulfonate (CHAPS) (GE Healthcare) and 30 mM Tris-HCl 
(pH 8.0) (PlusOne, GE Healthcare, Sweden). Samples were incubated at room temperature 
for 10 minutes followed by centrifugation (21500 × g, 20
o
C, 30 min) using centrifuge 
Himac CT 15RE (Hitachi Koki Co., Ltd, Japan).  
Protein samples were then purified using 2D Clean-Up Kit (GE Healthcare, Sweden). To 
the protein solutions (at a volume of 220 μl), 550 μl of the precipitant was added, the 
mixtures were incubated on ice for 15 min with frequent vortexing to ensure protein 
precipitations. Then, 550 μl of the co-precipitant was added to each sample, and the 
samples were briefly vortexed prior to centrifugation (21500 × g, 10 min, 4
o
C). After 
removal of supernatants, 50 μl of the co-precipitant was added without disturbing the pellet 
to cover the surface, and the tubes were centrifuged for 5 min at 4
o
C. Supernatants were 
discarded and 50 μl of MiliQ water was added and the samples were vortexed to break the 
protein pellets. Finally, ice-cold washing buffer (1 mL) together with 5 μl wash additive 
were pipetted to each sample, and the  samples were then incubated at -20
o
C for 30 min 
with repeated vortexing every 10 min before further analysis. 
Protein concentration in the samples was determined using the 2D Quant Kit (GE 
Healthcare, Sweden). Prior to quantification, wash buffer from purification step was 
removed after centrifugation at 4
o
C for 10 min. The residues of the buffer were dried for 2-
3 min in the open tubes. Next, UTC-T buffer was added to the precipitated protein and 
vortexed until protein pellet was dissolved. The samples typically required 80 μl of buffer. 
Protein solutions were centrifuged at 20
o
C for 10 min and supernatants were transferred to 
new tubes.  
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Quantitative assay was performed in triplicates according to protocol provided by 
manufacturer. For each sample 2 μl of protein solution were pipetted to a 1.5 ml tube, 
mixed with 500 μl precipitant from the kit, vortexed briefly and incubated for 2-3 min at 
room temperature. Next, 500 μl co-precipitant were pipetted into each tube followed by 
vortexing and centrifugation at 20
o
C for 5 min. Supernatant was thoroughly removed. To 
each tube 100 μl copper solution and 400 μl MiliQ water were added and mixed by 
vortexing to dissolve protein. Prior to assay an appropriate volume of working color 
reagent was prepared by mixing 100 parts of color reagent A from the kit with 1 part color 
reagent B. To each tube with protein sample 1 ml ready color reagent mix was pipetted and 
mixed by inversion followed by incubation for 15 min at room temperature. 
The absorbance of samples was read at 480 nm in 1.5 ml cuvettes (Brand GMBH, 
Germany) by spectrophotometer ORDIOR UV-1800 (Shimadzu, Japan) using MiliQ water 
as reference. Standard curve was generated using bovine serum albumin (BSA) solution 
provided with the kit. 
3.2.7 Two-dimensional gel electrophoresis  
3.2.7.1 Isoelectric focusing 
The IEF was performed using Ettan IPGphor 3 system (GE Healthcare, Sweden) with  11 
cm Immobiline DryStrip gel strips (IPG) of pH 4-7 (GE Healthcare, Sweden). Prior to IEF, 
IPG strips were rehydrated for at least 12 h in DeStreak rehydration solution (220 μl) 
containing 1% IPG buffer (GE Healthcare, Sweden) using the rehydration chamber. 
Samples to be loaded on IPG strips were composed to ensure equal amounts of protein (50 
µg), 1% IPG buffer (GE Healthcare, Sweden) and 50 mM DTT (SIGMA-ALDRICH). In 
addition,   2 μl bromphenol blue (PlusOne, Amersham Biosciences) was added to color the 
sample  Total volume of each sample was 60 μl and that was achieved by adding UTC-T 
buffer.  
Rehydrated IPG strips were placed on the IEF tray and the analyzed samples were applied 
using anodic cup-loading technique. The IEF-tray with loaded strips was filled with 
DryStrip Cover fluid (GE Healthcare, Sweden) to prevent drying of the strips. The loaded 
IPG strips were focused at 20 °C 500 V for 500 Vh, linear ramping to 1000 V for 800 Vh, 
linear ramping to 6000 V for 8800 Vh, hold at 6000 V for 2900 Vh, and step down to 500 
V. 
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After IEF the IPG strips were equilibrated in 2 mL equilibration buffer A consisting of 50 
mM Tris-HCl pH 6.8 (PlusOne, GE Healthcare, Sweden), 6 M urea (GE Healthcare), 2 % 
SDS (PlusOne, GE Healthcare), 20% glycerol (Merck KGaA, Germany), with 2 % (w/v) 
DTT (SIGMA-ALDRICH) for 15 min, followed by 15 min in 2 mL equilibration buffer B 
having the same composition except for having 2.5 % (w/v) iodoacetamide (Bio-Rad 
Laboratories, USA) instead of DTT. 
3.2.7.2 SDS-PAGE 
SDS-PAGE was performed using Criterion™ Precast gels in Criterion Dodeca™ cell (Bio-
Rad Laboratories, USA) enabling to run 12 gels at a time. IPG strips were carefully placed 
on top of the gel to ensure optimal contact between them. The running buffer (pH 8.3) was 
composed of 25 mM Tris, 192 mM glycine and 0.1% (w/v) SDS and was prepared by 10 
fold dilution of 10×TGS buffer (Bio-Rad Laboratories, USA). SDS-PAGE was run at the 
voltage of 200 V for approximately 58 min. 
3.2.8 Gel staining, image acquisition and data analysis 
Staining was performed using SyproOrange protein gel stain (SIGMA-ALDRICH). Prior 
to staining, gels were fixed for 1 h in fixing solution composed of  40% ethanol (Altia Oyj, 
Finland), 2% acetic acid (Merck KGgA, Germany) and 0.0005% SDS (PlusOne, GE 
Healthcare). After fixation, gels were rinsed twice in MilliQ water and then immersed into 
staining solution containing 0.02% Sypro Orange stain, 2% acetic acid and 0.0005% SDS 
(PlusOne, GE Healthcare). The staining was performed for 1 hour followed by rinsing 
twice with MiliQ water. The gels were then stored in MiliQ water.  
The gel images were acquired using AlphaImager HP set at aperture 2, zoom 17.50 and 
auto focus as well as AlphaView-AlphaImager HP software (ProteinSimple, USA). 
Analysis of the gel images was performed using SameSpots software (Totallab, UK). The 
gel images were aligned by automated calculation of alignment vectors after assigning 40–
80 landmark vectors depending on the quality of gels. An ANOVA with p-value ≤0.05 was 
chosen to identify significant changes in spot volume values between what conditions. 
Another selection criterion for differentially expressed proteins was maximal fold change 
that was set at ≥1.5. 
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3.2.9 Spot picking and protein identification 
In order to visualize protein spots for identification, re-staining with silver staining method 
(O'Connell and Stults 1997) was applied. For this purpose, gels were fixed for at least 1 h 
in fixing solution composed of 30% ethanol (Altia Oyj, Finland), 0.5% acetic acid (Merck 
KGgA, Germany), at the same time ensuring removal of the Sypro Orange stain, followed 
by rinsing in 20% ethanol for 10 min and in MilliQ water for 10 min. Next, the gels were 
sensitized in 0.2% sodium thiosulfate solution (Merck KGgA, Germany) for 1 min and 
rinsed with MiliQ water for 20 s twice. Staining was applied as holding in 0.2% silver 
nitrate solution for 30 min followed by rinsing with MiliQ water for 10 s twice. Next, the 
stain was developed by immersing gels to dedicated solution composed of 3% potassium 
carbonate (Merck KGgA, Germany) with 50 ml/l sensitization solution (see above) and 
700 μl/l of 37% formaldehyde (Merck KGgA, Germany) typically for 1 to 5 min to achieve 
the desired intensity. Finally, the staining was terminated by holding in stop solution 
composed of 5% Trizma®Base (SIGMA-ALDRICH) and 2.5% acetic acid for 1 min. 
Spots collection was performed by means of 1.5 mm spots picker P2D 1.5 (The Gel 
Company, USA). Gel specimens containing protein samples were stored at -20
o
C before 
further analysis.  
Protein specimens were subjected to trypsin digestion to yield peptide mixtures. The 
identification was conducted in Biocenter (Viikki campus, University of Helsinki). 
Peptides were then analyzed with liquid chromatography tandem mass spectrometry (LC-
MS/MS) using QSTAR Mass Spectrometer (Applied biosystems/MDS Sciex). The data 
obtained was analyzed with ProteinPilot™ Software (AB SCIEX) and run against NCBI 
database using MASCOT search engine. In order to obtain the information about proteins 
several databases were employed including KEGG, Uniprot and BRENDA.
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4. RESULTS 
4.1 Growth kinetics 
The growth rates of P. freudenreichii DSM 20271 during logarithmic phase in DMBI+ and 
DMBI+ condition were similar to each other (Fig. 9). Mean generation time values were 
4.3 and 4.4 h, respectively. The culture grown in PPA medium without cobalt and DMBI 
supplementation had generation time of 4.1 h. However, supplementation with cobalt and 
DMBI enabled to achieve higher cell density. The final OD600 measured at 76 h incubation 
was highest in DMBI+ culture (OD600=3.7) as compared to DMBI- (OD600=3.46) and PPA 
(OD600= 3.19).  
 In order to obtain bacterial cells for 2-D electrophoresis at mid-logarithmic growth stage 
the harvesting time was set at 24 h, when values of the OD600 were 0.56-0.91 in DMBI+ 
and 0.61-0.76 in DMBI- condition.  
 
Figure 9. Growth curve of P. freudenreichii DSM 20271 cultivated in liquid PPA medium with different 
supplementations. Harvesting time at mid-logarithmic phase is marked with an arrow 
 
4.2 Vitamin B12 production  
Cobalamin levels were determined for DMBI- and DMBI+ condition from three biological 
replicate cultures. The levels were expressed in ng per cell pellet mass as well as 
volumetric productivity in ng per ml of media volume. Volumetric productivity reveals the 
47 
 
 
efficiency of the whole process. The measurements were made at logarithmic growth stage 
(24 h) and after 168 h incubation. Measurements at 24 h were made for cultures grown in 
230 ml PPA media. Determination after 168 h was done for cells harvested from 21 ml 
culture medium left from harvesting for 2D GE analysis. Three replicates of both DMBI- 
and DMBI+ cultures were grown under anaerobic condition during all 168 h. Three more 
replicates of each condition were grown in two step fermentation process, i.e. when after 
72 h incubation samples were transferred to aerobic condition for the rest 96 h. 
In mid-logarithmic phase at 24 h the level of cobalamin in DMBI+ samples was around 
twice as high as in DMBI- (15.8 against 30.1 µg/g pellet) (Fig. 10). Volumetric 
productivity was also higher in DMBI-supplemented samples (0.044 against 0.025 µg/ml) 
(Fig. 11). 
By the end of fermentation (168 h) in the absence of oxygen, cobalamin level increased 
around 8-fold in DMBI- cultures and almost 12-fold in DMBI+ cultures (Fig. 11). The 
resulting vitamin levels were 0.2 and 0.53 µg/ml, respectively. Thus, in DMBI 
supplemented samples cobalamin level was around 2.7 times as high as in the absence of 
DMBI. In terms of B12 level in relation to cell mass, the increase is not as dramatic as in 
case of volume productivity. In DMBI- cultures by the end of fermentation there was slight 
increase from 15.8 to 17.1 µg/g (Fig. 10). In DMBI-supplemented cultures cobalamin level 
rose from 30.1 to 38.6 µg/g. 
In the samples to which two-step process was applied higher cobalamin levels were found 
both in presence and absence of DMBI. In DMBI- cultures final level of cobalamin was 
around 51% higher than in the cultures grown anaerobically for 168 h. In case of DMBI+ 
samples the increment was about 15.5%.  Final cobalamin levels in DMBI- and DMBI+ 
cultures grown in two-step process were 0.3 and 0.6 µg/ml, respectively. Thus, the highest 
cobalamin level was achieved in presence of DMBI combined with two-step fermentation. 
In terms of B12 level per cell mass in the absence of DMBI, the increment resulting from 
incubation under aerobic condition for the last 96 h was about 21%. As for DMBI+ 
samples no significant increase was observed.  
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Figure 10. Cobalamin levels produced by P. freudenreichii DSM 20271 cultures, µg/g cell  pellet. Black bars 
– DMBI+ condition, Diagonal fill bars – DMBI- condition. DMBI- 168h and DMBI+ 168h were incubated 
anaerobically. DMBI-/+O2 168h and DMBI+/+O2 168h were grown in two-step process including 72 h 
anaerobic incubation followed by 96 h aerobic incubation. Error bars show standard deviations. 
 
Figure 11. Volumetric production of cobalamin by P. freudenreichii DSM 20271 cultures, µg/ml medium. 
Black bars – DMBI+ condition, diagonal fill bars – DMBI- condition. DMBI- 168h and DMBI+ 168h were 
incubated anaerobically. DMBI-/+O2 168h and DMBI+/+O2 168h were grown in two-step process including 
72 h anaerobic incubation followed by 96 h aerobic incubation. Error bars show standard deviations. 
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4.3 Proteome maps of P.freudenreichii at mid-logarithmic growth stage 
Global protein production in P. freudenreichii DSM 20271 at the mid-logarithmic growth 
stage was studied by means of 2D gel electrophoresis. Six biological replicate cultures for 
each of two conditions (DMBI+ and DMBI-) were used for preparing cell samples. 
Proteins extracted from these samples were first separated on immobilized pH gradient 
strips in the pH range from 4 to 7. In the second dimension proteins were separated 
according to molecular weight in polyacrylamide gels. Proteome maps for DMBI+ and 
DMBI- conditions were obtained by visualization of gels using Sypro Orange staining. The 
images were processed using the SameSpots software. At the stage of alignment one 
replicate of DMBI- condition was excluded, and further analysis was conducted with five 
replicates for DMBI- and six replicates for DMBI+ condition. 
In total, 474 spots were detected. Principle component analysis (PCA) was performed for 
all spots detected on six gels of DMBI+ and five gels of DMBI- conditions. It showed no 
significant difference in protein production between these two conditions (Fig. 12). 
 
 
Figure 12. Principle component analysis on spots detected in proteome maps obtained for DMBI- and 
DMBI+ condition. Individual gels are represented as ● (DMBI-) and ◘ (DMBI+) 
PCA was also performed only on the spots which had significantly different abundance 
(ANOVA p-value ≤ 0.05) between condition DMBI- and DMBI+.  It showed separation of 
gels according to the condition (Fig. 13). Principle component 1 accounted for 65.2% of 
variation between the groups which is much higher than in PCA performed on all the spots 
(28.8%).  
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Figure 13. Principle component analysis on spots showing significantly different abundance between 
conditions DMBI- and DMBI+ (ANOVA p-value≤0.05). Individual gels are represented as ● (DMBI-) and ◘ 
(DMBI+) 
 
Proteome maps of mid-logarithmic P. freudenreichii cultures are given in Fig. 14 and 15. 
Only six spots showed clear differences in relative abundance between DMBI+ and DMBI- 
condition, i.e. had ANOVA p-value ≤0 0   They were selected for further analysis  Among 
them the abundance of four spots had maximum fold change ≥     The abundance of spots 
5 and 6 had fold change of 1.3 and 1.4, respectively (Table 1), which is less than the 
selection criteria. Nevertheless, they were selected for further analysis as they had 
ANOVA p-value below 0.05. 
The abundance of only two proteins (corresponding to spots 1 and 5) (Fig. 14) was higher 
in presence DMBI+ condition (positive fold change values in Table 1). Other four spots 
(Fig. 15) were significantly more abundant in the absence of DMBI (negative fold change 
values in Table 1).  
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Figure 14. Proteome map of mid-logarithmic culture of P. freudenreichii DSM 20271 grown in PPA 
medium supplemented with 15 ppm DMBI. Spots 1 and 5 outlined and marked with arrows showed higher 
abundance in DMBI+ condition as compared to DMBI- condition 
 
Figure 15. Proteome map of mid-logarithmic culture of  P. freudenreichii DSM 20271 grown in PPA 
medium without DMBI supplementation. Spots 2, 3, 4, 6 outlined and marked with arrows showed higher 
abundance in DMBI- condition as compared to DMBI+ condition 
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4.4 Identification of six selected proteins spots  
All six protein spots which showed differential abundance (ANOVA p-value ≤0 0 ) 
between DMBI+ and DMBI- conditions were identified and assigned to database entries 
using KEGG, Uniprot and BRENDA databases. A list of all identified proteins, including 
accession ID, sequence coverage, Mascot scores, theoretical pI values and molecular 
weights are shown in Table 1. Several proteins were identified for spots 2, 3, 4, 6 with 
varying sequence coverage. 
Only two protein spots (1 and 5) were more abundant in presence of DMBI. Proteins which 
could have been induced in this condition included 50S ribosomal protein L7/L12 and 
carboxylic ester hydrolase identified in spots 1 and 5, respectively. 
Other four protein spots (2, 3, 4, 6) were more abundant in DMBI- condition. A group of 
ribosomal proteins were identified in spots 2 and 3. It is noteworthy that spots 1 (more 
abundant in DMBI+) and 3 are located close to each other in the same part of gels close to 
anodic end (Fig. 12 and 13). Most proteins identified for spot 3 are basic with pI values 
near or above 10. This does not agree with the position on the gel.  
Five proteins were identified in spot 4, however, it was cysteine synthase encoded by cys2 
gene which had the however highest Mascot score. Transporter proteins including ABC 
transporter ATP-binding proteins and  branched-chain amino acid ABC transporter ATP-
binding protein were among the identifications in spots 2 and 4. In addition, protein 
involved in lipid metabolism and energy production proteins were identified in these spots 
as well with lower score and sequence coverage. They included glycerophosphoryl diester 
phosphodiesterase, anaerobic glycerol-3-phosphate dehydrogenase subunit A. 
No exact gene names were found for protein from the spot 6. The protein identified with 
the highest score was oxidoreductase which could also be a part of lipid metabolism and 
energy production pathways. 
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Table 1. Identification of protein spots from proteome maps of mid-logarithmic cultures of P. freudenreichii ssp. freudenreichii DSM 20271. Spots showed significant differences in abundance in 
response to presence (DMBI+) and absence of DMBI (DMBI-). Spot numbers refer to Fig. 14 and 15  
Spot 
No Gene Description pI Mw Score 
Sequence 
coverage, 
% 
Fold change of 
DMBI+ relative 
to DMBI- 
ANOVA p-
value 
Accession 
number 
1 rplL 50S ribosomal protein L7/L12 4.46 13657 1110 89 2.3 0.042 gi|297625768 
2 rpsA 30S ribosomal protein S1 4.61 53583 1923 68 
-1.6 0.034 
gi|297626694 
glpA 
anaerobic glycerol-3-phosphate 
dehydrogenase subunit A 
5.58 
59534 695 27 gi|297626480 
pyrG CTP synthase 6.2 64293 455 15 gi|297626545 
PFREUD_07970* ABC transporter ATP-binding protein 4.9 62791 295 9 gi|297626001 
3 
rplR 50S ribosomal protein L18  11,4 14014 332 58 
-2 0.042 
gi|297625798 
rplU 50S ribosomal protein L21  9,73 11235 182 53 gi|297626047 
rpsM 30S ribosomal protein S13 10,73 14018 121 43 gi|297625815 
rplT 50S ribosomal protein L20  10,84 13878 118 26 gi|297626568 
rplN 50S ribosomal protein L14  10,01 13450 100 41 gi|297625792 
rplS 50S ribosomal protein L19  10,36 13247 100 30 gi|297626591 
rsfS ribosomal silencing factor  4,63 14153 72 24 gi|297626056 
rplL 50S ribosomal protein L7/L12  4,46 13657 55 19 gi|297625768 
rplW 50S ribosomal protein L23 9,64 11519 54 41 gi|297625784 
4 cys2 cysteine synthase 5.14 33620 357 30 
-1.5 0.017 
gi|297626804 
PFREUD_06120* ABC transporter ATP-binding protein 5.88 30956 309 20 gi|297625365 
ugpQ2 
glycerophosphoryl diester 
phosphodiesterase 
4.6 
28117 186 16 gi|297627469 
livF 
branched-chain amino acid ABC 
transporter ATP-binding protein 
6.19 
25206 103 10 gi|297626278 
PFREUD_01850* dihydroorotate dehydrogenase 4.76 40774 99 12 gi|297625388 
5 pf2042 carboxylic ester hydrolase 4.63 35294 449 23 1.3 0.047 gi|297627526 
6 PFREUD_18650* oxidoreductase 5.56 29476 516 26 
-1.4 0.046 
gi|297627014 
CAD48741* putative phosphoglycerate mutase 5.86 28351 229 26 gi|76556217 
* locus in reference genome for proteins with no detailed information available
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5. DISCUSSION 
5.1 The effect of DMBI on cell growth 
DMBI was added to the cultures at the beginning of incubation. The cell growth in P. 
freudenreichii was not considerably affected by DMBI supplementation as compared to 
non-supplemented culture. This is in agreement with recent study by Wang et al. (2012) 
who reported no significant effect of DMBI on growth of P. freudenreichii CICC 10019 
regardless the time of addition (Wang et al. 2012). However, the earliest time for DMBI 
addition used in their study was after 24 h of incubation and the level of DMBI was only 
0.9 mg/l. By contrast, Marwaha et al. (1983) showed that DMBI infused at the early stages 
of growth (0 and 48 h) at the level of 15 ppm inhibited the growth of P. shermanii 566 and 
Propionibacterium arl AKU, 1251 which resulted in reduced B12 biosynthesis. Since 
assimilation of lactose from the media in this experiment was not affected, authors 
speculated that the cultures inhibited by early DMBI addition consumed energy more 
actively to overcome the constraining action of the compound (Marwaha et al. 1983). 
5.2 The effect of exogenous DMBI in growth medium on vitamin B12 biosynthesis 
The attachment of lower ligand containing DMBI is the last step of coenzyme B12 
(cobalamin) formation. In industrial two-step bioprocess formation of DMBI is facilitated 
by aeration at the second stage. Aeration is provided for a few days during which 
endogenous DMBI moiety is formed and linked to cobinamide (Survase et al. 2006). 
Alternatively, exogenous DMBI is added to the culture media and the process can be 
conducted anaerobically, i.e. independent from endogenous synthesis of the precursor 
(Wang et al. 2012).  
In available studies, addition of DMBI is normally performed in the stationary phase which 
restricts possible comparison of our results with other studies. The late DMBI addition 
strategy was substantiated in the study by Marwaha et al. (1983). Reduced B12 
biosynthesis by P. shermanii 566 and Propionibacterium arl AKU, 1251 was attributed to 
growth inhibition if DMBI was added at 0-96 h fermentation. The study recommended the 
infusion of DMBI 24 h before the end of incubation (Marwaha et al. 1983). Cobalamin 
levels were determined using spectrophotometric technique and expressed in µg/g 
lactose∙h-1 which makes it difficult to compare the results with our cobalamin levels.  
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In agreement with previous reports, our results indicate that DMBI supplementation 
considerably enhanced cobalamin biosynthesis. The final level of 0.6 µg/ml obtained in for 
DMBI-supplemented culture of P. freudenreichii DSM20271 in two-step process was 
lower than that reported by Hugenschmidt et al. (2010) for the same strain which was 0.9 
µg/ml. This study employed similar protocol for cultivation and the same level of DMBI. 
However, in this work DMBI was added 24 h before the end of fermentation (at 144 h). 
Another difference is that the media used in this screening study was supplemented whey 
permeate (SWP). Vitamin B12 level was determined using HPLC likewise. This screening 
study on 37 P. freudenreichii strains showed that the species B12 productivity varies in the 
range 0.0-2.5 µg/ml and on average is higher than that of other species. The highest B12 
level of 2.5 µg/ml was reported for strains DF17 and DF28 derived from raw milk 
(Hugenschmidt et al. 2010).  
Another study by Quesanda-Chanto et al. (1998) on P. freudenreichii DSM20271 reported 
considerably higher level of B12 which was 2.7 µg/ml as determined by HPLC method. 
The strain was cultivated in the medium containing glucose as carbon source at 35
o
C and 
controlled pH at 6.5. No supplementation with DMBI was involved, only cobalt at the 
level of 10 mg/l was added. The level of vitamin B12 was high considering that the 
fermentation lasted only 72 h strictly under anaerobic condition (Quesada-Chanto et al. 
1998). 
Ye et al. (1996) also investigated the same strain of P. freudenreichii DSM 20271 (under 
the name IFO 12424) obtained from a different collection. They reported that fully 
anaerobic fermentation with DMBI added from the very beginning for 68 h yielded 4.64 
µg/ml B12 determined spectrophotometrically. This amount is considerably higher than the 
one obtained in our work (0.53 µg/ml). This may be due to higher levels of DMBI and 
cobalt which were 70mg/l and 50 mg/l, respectively (Ye et al. 1996). 
Recent study by Wang et al. (2012) confirmed the importance of DMBI addition timing. 
The optimal time for DMBI infusion was corresponding to the highest level of 
intermediate compound adenosyl-cobinamide. In this study DMBI level was only 0.9 
mg/ml and corn steep liquor was used as growth medium. DMBI addition was followed by 
immediate conversion of cobinamide to cobalamin. Earlier or delayed DMBI infusion 
resulted in lower cobalamin yield. The highest adenosylcobalamin yield achieved for P. 
freudenreichii CICC 10019 was of about 21 µg/ml when DMBI was added at 84 h 
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anaerobic incubation at maximum adenosyl-cobinamide level, total incubation time being 
120 h (Wang et al. 2012). 
Berry and Bulllerman (1966) reported higher cobalamin levels determined using 
microbiological assay in P. shermanii ATCC 13973 grown in whey-based medium. At the 
same level of DMBI (15 ppm) and cobalt (5 ppm) and 168 h anaerobic incubation the final 
cobalamin level was 5.95 µg/ml. It was considerably higher than in the cultures not 
supplied with DMBI (2.08 µg/ml). However, at lower DMBI concentration of 10 ppm even 
higher B12 productivity was achieved (6.35 µg/ml) (Berry and Bullerman 1966). 
Yongsmith et al. (1982) used immobilized cells of Propionibacterium arl AKU 1251 
cultivated for five days and DMBI was added at the third day. The final B12 amount 
produced were about 7 µg/ml and 4.96 µg/ml at DMBI level of 20 mg/l and 10 mg/l, 
respectively (determined by microbial assay). This was considerably higher than in the 
absence of DMBI which was about 4.3 µg/ml (Yongsmith et al. 1982).  
5.3 The effect of two-step incubation on cobalamin productivity 
P. freudenreichii is anaerobic and aerotolerant bacterium which produces cobalamin in 
high yields only under low level of oxygen (Survase et al. 2006). However, biosynthesis of 
DMBI requires oxygen. This conditioned the development of two-step fermentation 
process consisting of anaerobic step followed by shift to aeration for a few more days 
(Speedie and Hull 1960; Vandamme 1992).  
Our results indicate considerable improvement in B12 productivity achieved in two-step 
process in the absence of DMBI. These results are in agreement with the study by Berry 
and Bullerman (1966) in which aeration at the rate 215 ml air/(l∙min) increased cobalamin 
production by P. shermanii ATCC 13973  from about 2.08 µg/ml to 11.2 µg/ml. Higher 
aeration rate was not necessary to enhance productivity. However, the highest B12 level 
(15.04 µg/ml) produced in the absence of DMBI was achieved with high aeration intensity 
(1000 ml air/(l∙min)) and cobalt level of cobalt (15 ppm) (Berry and Bullerman 1966).  
In DMBI-supplemented cultures aerobic stage of incubation also increased cobalamin 
production compared to fully anaerobic fermentation, although to a lesser extent. Even 
though in our work aeration intensity was not controlled, these results disagree with Berry 
and Bullerman (1966). Their study indicated that DMBI combined with aeration had 
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negative effect on B12 production. Hence, no DMBI addition was recommended when low 
aeration rate was applied (Berry and Bullerman 1966). 
Ye et al. (1966), who worked with the same strain P. freudenreichii DSM20271, developed 
cultivation system with periodic variation of dissolved oxygen level which had a great 
influence on B12 production. It was demonstrated that shift to aerobic condition for a short 
period (up to 6 h) results in decomposition of propionate. Propionate accumulated in large 
amounts during anaerobic growth has an inhibitory effect on bacterial cells. Therefore, 
periodic aerobic incubation enabled higher cell growth. This resulted in increased B12 
production. The cell density after 68 h fermentation using periodic system grew as high as 
15.02 g/l which was three times as high as in fully anaerobic process. This resulted in 
production of 9.54 µg/ml B12, which was almost twice as high as when no aeration was 
provided. DMBI was provided in the medium from the time 0 at higher level than in our 
work (70 mg/l) (Ye et al. 1996). This indicated that B12 productivity by P. freudenreichii 
DSM20271 can be significantly improved by the combination of DMBI supplementation 
and aeration. 
5.4 Effect of DMBI on protein production 
5.4.1 Protein production was not significantly affected by exogenous DMBI in relation to 
cobalamin biosynthesis 
The predicted proteome for P. freudenreichii contains 2439 proteins (Falentin et al. 2010). 
In this work, in total 474 spots were detected using 2D electrophoresis within pH range 
from 4 to 7. This constitutes less than 20% of the total P. freudenreichii proteome. Hence, 
many proteins including membrane-associated, basic and low-abundant ones were missed 
out from the analysis. This is one of the shortcomings of 2D gel electrophoresis. The 
alternative to this can be the technique that overcome the difficulties with protein 
solubilization, e.g. a GeLC MS/MS method. It involves separation of proteins in 
polyacrylamide gel followed by in-gel digestion and identification of peptides using  nano-
LC MS/MS.  It enables to maximize the number of identifications in bacterial proteome 
(Savijoki et al. 2011). 
No considerable differences were found in proteome maps between DMBI+ and DMBI- 
conditions. Differentiation between two conditions could be achieved only based on the 
abundance of six spots. It is noteworthy that protein production was studied at the mid-
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logarithmic growth stage. Cobalamin at this stage was produced in very little amounts. 
Major part of the vitamin was produced during stationary phase. Cobalamin biosynthetic 
pathway includes about 30 enzyme-mediated steps (Raux et al. 2000). P. freudenreichii 
produces cobalamin using anaerobic (early cobalt insertion) pathway (Martens et al. 2002). 
However, it synthesizes DMBI at presence of oxygen (Renz 1998). Aerobic DMBI 
biosynthesis is known to be catalyzed by BluB enzyme which utilizes riboflavin as a 
substrate and belongs to a family of ‘flavin destructase’ (Taga et al. 2007). In P. 
freudenreichii bluB gene was found to be fused with cobT gene encoding the enzyme 
activating DMBI before the attachment to corrin ring. Production of proteins involved in 
neither cobalamin nor DMBI biosynthesis was found to be affected in P. freudenreichii by 
exogenous DMBI in the medium during the logarithmic growth stage.  
5.4.2 Cysteine synthase may have been induced in the absence of DMBI 
The identification with the highest score for spot 4 was cysteine synthase encoded by cys2 
gene. The protein was induced in the absence of DMBI in the growth medium. In total, 
three cysteine synthases were found in P. freudenreichii CIRM-BIA1
T
 genome according 
to UniProt database (encoded by cys1, cys2 and cysK). The pI value of Cys2 enzyme is 
5.14 and that does not agree well with the position of the protein on the gel closer to pH 7 
end.  
Cysteine synthase is involved in sulfur-containing amino acids metabolism. It transfers 
sulfhydryl group from hydrogen sulfide to O3-acetyl-L-serine to yield L-cysteine. Cysteine 
then can enter transsulfation pathway of methionine biosynthesis. It is converted to 
methionine in three steps via cystathionine and homocysteine (Rodionov et al. 2004). 
Methionine participates in the biosynthesis of macroring structure of cobalamin. Corrin 
ring is formed from all carbons of ALA and methyl carbons of L-methionine (Iida and 
Kajiwara 2000). Seven methyl groups of corrin ring are derived from methyl groups of L-
methionine (Scott et al. 1972).  
As it was mentioned before, the abundance of proteins directly involved in cobalamin 
biosynthesis was not changed by presence or absence of DMBI. However, enhanced 
cysteine synthesis might have led to active methionine production. Methionine then could 
be used by bacteria to produce precursor of cobalamin. It is unclear why it was DMBI- 
condition in which cysteine synthase was expressed to higher extent. As it is seen from 
cyanocobalamin levels at 24 h, the vitamin production was lower in the absence of DMBI 
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at this early growth stage. However, only the whole vitamin level was controlled and no 
investigation was made on the amount of B12 precursors bacteria were producing.  
Therefore, it is hard to conclude if the cobalamin synthesis was stimulated due to enhanced 
cysteine synthase production in the cultures growing without exogenous DMBI. 
On the other hand, cysteine synthase encoded by cys2 gene appeared to be induced in P. 
freudenreichii SI41 by bile stress. The enzyme was homologous to cysteine synthase in B. 
subtilis which was known to participate in oxidative stress adaptation (Leverrier et al. 
2003). In P. freudenreichii cysteine synthase A was induced in response to heat stress. It 
was suggested to participate in the repair of damaged cells (Anastasiou et al. 2006). In 
another study, production of cysteine synthase encoded by cysK gene was shown to be 
stimulated by detergent and heat, but not acid, stresses (Vorobjeva et al. 2004).  
5.4.3 Ribosomal proteins were induced in both absence and presence of DMBI 
Some proteins that appeared to be affected by DMBI belong to the group of ribosomal 
proteins. In prokaryotes ribosomes consist of two subunits: large (50S) and small (30S) 
(Aseev and Boni 2011). Ribosomes include from 50 to 80 ribosomal proteins. The 
interaction between ribosomal proteins and rRNA is essential for optimal ribosome 
functioning and translation (Wilson and Nierhaus 2005). Apart from their role in 
translation regulation, some ribosomal proteins were found to exhibit moonlighting 
properties (Aseev and Boni 2011). Moonlighting is the performance of more than one 
function by a single protein. The phenomenon was recognized in 1980s and different 
protein classes were found to exert moonlighting. Additional functions can be fulfilled if 
proteins are able to use different regions of protein structure, due to post translational 
modifications and/or differences in binding patterns (Copley 2012). 
Most of ribosomal proteins are basic. In E. coli ribosomal proteins were separated by 2D-
PAGE  Eleven of the 30S and ten of the  0S proteins had pI values ≥ 2 0, whereas seven 
of the 30S and fifteen of the 50S proteins had pI values of ≤ 0 0 (Kaltschmidt 1971). The 
basic nature of most ribosomal proteins is due to their function, i.e. interaction with 
negative charges of the phosphate residues in rRNA backbone. A few exceptions include 
proteins S1 and L7/L12 as they interact with other proteins within ribosome (Wilson and 
Nierhaus 2005).  
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50S ribosomal protein L7/L12 identified in spot 1 was significantly more abundant in the 
presence of exogenous DMBI in the medium. It is an acidic protein with pI of 4.46. The 
spot was located in the left part of the gel accordingly. Unlike other ribosomal proteins 
L7/L12 is a dimer present in more than one copy in 50S ribosome (Aseev and Boni 2011). 
L7/L12 interacts with another protein L10 within ribosome forms pentameric complex 
L10×(L7/L12)4 which is stable and can partially resist 6 M urea. L7/L12 forms a 
characteristic structure of 50S subunit referred to as L7/L12 stalk.  L7/L12 is involved in 
recognition and binding of elongation factors and stimulation of GTPase (Wilson and 
Nierhaus 2005). In E. coli the protein was found to fulfill a moonlighting function of an 
operon-specific translational repressor. The mechanism of translation inhibition has not 
been elucidated yet but L10×(L7/L12)4 appears to be involved in binding mRNA (Aseev 
and Boni 2011). 
50S ribosomal protein L7/L12 was also among the identifications for the spot 3 located 
close to spot 1 on the gel. However, this identification had very low score of 55 and 
sequence coverage of 19% only as compared to 89% for spot 1 identification. This can be 
the result of the neighboring location of two spots on the gel. 
In the absence of DMBI  30S ribosomal protein S1 identified with the highest score in spot 
2 was induced. It is an acidic protein with pI value of 4.61 which agrees with the spot 
position on the gel. S1 is the largest ribosomal protein. It is responsible for binding of 
mRNA to the 30S subunit at the initial stage of translation (Wilson and Nierhaus 2005). 
Besides RNA, S1 is also capable of protein-protein interaction. It is the reason for S1 
fulfilling numerous functions besides the main one. One of the moonlighting functions of 
S1 is regulation of translation as it was shown to inhibit the translation of its own mRNA 
(Aseev and Boni 2011). 
Among several ribosomal proteins identified for spot 3 only ribosome recycling protein 
(encoded by rsfS gene) had pI value (4.46) which agreed with the spot location on the gel. 
In P. freudenreichii CIRM-BIA1
T
 it interacts with ribosomal protein L14 (encoded by rplN 
gene), blocking formation of intersubunit bridge, thus preventing association of the 30S 
and 50S ribosomal subunits. This results in translation repression (Falentin et al. 2010). 
RplN protein was also identified in the same spot. However, its pI value of 10.01 disagrees 
with the spot location on the gel. 
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Seven ribosomal proteins identified in spot 3 (encoded by rplR, rplU, rpsM, rplT, rplN, 
rplS, rplW genes) that are basic with pI values around 10.0 or higher. It is unclear how 
these proteins could appear in the acidic region of the gel. Since the spot 3 is localized in 
the edge of the gel it can be suggested that during IEF basic proteins did not move along 
the IPG strip from anodic end of IPG strip (pH around 4.0) where the loading was done. In 
early gel-based separation of E. coli ribosomal proteins in the first dimension was achieved 
using gels with discrete pH values (Kaltschmidt 1971). It can also be suggested that 
ribosomal proteins were not properly solubilized since they are known to form complexes 
with each other like in case with L10×(L7/L12)4 complex which is stable at high urea 
levels (Wilson and Nierhaus 2005). 
Thus, the differential abundance of ribosomal proteins can indicated that translation was 
affected by DMBI. Also, ribosomal proteins are able to fulfil moonlighting function and 
they could also be somehow influenced. However, the exact relation between presence of 
DMBI and ribosomal proteins is not clear.   
5.4.4 Carboxylic esterase may have been induced in the presence of DMBI 
In the presence of DMBI the abundance of protein spot 5 is the second spot that was higher 
than in DMBI-. However, the fold change was below 1.5. The only identification for spot 5 
was putative carboxylic ester hydrolase encoded by pf2042 gene. Its pI value of 4.63 
agrees with position of the spot on the gel. In P. freudenreichii genome, twelve carboxylic 
esterases were found (Falentin et al. 2010). Pf2042 enzyme was found to be an intracellular 
esterase (Dherbecourt et al. 2010) but it has not been studied in details. It is involved in 
lipids metabolism although its exact function is not clear. 
5.4.5 In the absence of DMBI ABC transporter ATP-binding proteins may have been 
induced 
Three ABC transporter ATP-binding proteins could have been affected by the absence of 
DMBI. One of the proteins was branched-chain amino acid ABC transporter ATP-binding 
protein encoded by livF identified in spot 4. Two others were among the identifications in 
spot 2 and 4. They are involved in transport and binding of proteins and lipoproteins but 
their exact functions are unclear. In P. freudenreichii some ABC transporters were 
previously reported to be involved in bile stress specific response. It was suggested that 
they could be a part of efflux system for detoxification (Leverrier et al. 2004). Some ABC 
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transporters were also found to be induced during heat stress adaptation (Anastasiou et al. 
2006). 
5.4.6 Lipid metabolism and energy production proteins induced in the absence of DMBI  
The abundance of three proteins induced in the absence of DMBI might be related to lipid 
metabolism and energy production. Glycerophosphoryl diester phosphodiesterase encoded 
by ugpQ2 gene was identified in the spot 4. The enzyme catalyzes hydrolysis of 
glycerophsphodiesters yielding respective alcohol and glycerol-3-phosphate (G3P). In E. 
coli the enzyme was shown to have broad substrate specificity and overexpressed in 
response to phosphate starvation. Under this condition E. coli appeared to utilize 
glycerophsphodiesters as a source of phosphate (Ohshima et al. 2008). 
The second highest score identification in spot 2 was anaerobic glycerol-3-phosphate 
dehydrogenase subunit A. The enzyme is encoded by glpA gene and was also induced in 
the absence of DMBI. It is involved in ATP-generating electron transport pathway. It 
converts G3P into dihydroxyacetone phosphate. In E. coli GplA is a part of G3P 
dehydrogenase operon and was shown to form a dimer GlpAB carrying the catalyzing site 
for G3P oxidation. The third subunit of the operon, GlpC, accepts reducing equivalents 
from GlpAB. Oxidoreductase identified with the highest score for spot 6 was found to be 
homologous to GlpC of E. coli. GlpC has iron-sulfur cluster binding property using 
cysteine rich regions (Cole et al. 1988). According to the Mascot database, oxidoreductase 
of P. freudenreichii also had iron-sulfur binding region.  Thus, the three enzymes could 
constitute successive catalysis of reactions that were involved in glycerophospholipids 
metabolism and energy generation by the cells grown without exogenous DMBI.
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6. CONCLUSIONS 
The study evaluated the effect of exogenous DMBI in growth medium on vitamin B12 
synthesis and protein production in P. freudenreichii ssp. freudenreichii DSM 20271.  The 
growth of P. freudenreichii was not inhibited by DMBI added to the medium at the 
beginning of incubation.  
DMBI supplementation resulted in 2.7-fold higher level of vitamin B12 compared to the 
culture grown in absence of DMBI. In addition, two-step process combined with DMBI 
supplementation enabled the improvement of volumetric productivity of cultures as 
compared to cultures grown fully anaerobically. This may indicate that in two step process 
P. freudenreichii utilizes exogenous DMBI and produces its own DMBI during aerobic 
stage for complete cobalamin synthesis simultaneously. On the other hand, aeration could 
result in decomposition of propionate as an inhibitory agent for P. freudenreichii cells.  
The highest level of vitamin B12 of 0.6 µg/ml was achieved in two-step process. It is less 
than in other studies using the same strain but different media, the level and the time of 
DMBI addition. Hence, the growth conditions for P. freudenreichii ssp. freudenreichii 
DSM 20271   can be optimized for better productivity. 
Proteome maps were obtained for mid-logarithmic cultures grown in absence and presence 
of DMBI under anaerobic condition using 2D gel electrophoresis. Less than 20% of total 
P. freudenreichii proteome was displayed on the proteome maps. The 2D GE method may 
require optimization in order to maximize the number of proteins that can be detected. 
The analysis of proteome maps for DMBI- and DMBI+ conditions showed no significant 
differences in protein production between them. Only six protein spots showed significant 
differences in abundance. The abundance of proteins directly involved in vitamin B12 
biosynthesis was not found to be affected in presence or absence of DMBI. The only 
indirect evidence of cobalamin biosynthetic pathway to be affected was higher abundance 
of cysteine synthase in DMBI- as compared to DMBI+ condition. Cysteine synthase could 
supply cysteine for further conversion to methionine which, in its turn, could be used for 
corrin ring formation. Possible involvement of cysteine synthase in vitamin B12 synthesis 
in the absence of DMBI could be investigated further by the analysis of intermediate 
compounds present before the attachment of DMBI to coring ring.
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